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Abstract
Higher organisms, such as humans, have an adaptive immune system that usually
enables them to successfully combat diverse (and evolving) microbial pathogens. The
adaptive immune system is not preprogrammed to respond to prescribed pathogens,
yet it mounts pathogen-specific responses against diverse microbes, and establishes
memory of past infections (the basis of vaccination). Although major advances have
been made in understanding pertinent molecular and cellular phenomena, the mech-
anistic principles that govern many aspects of an immune response are not known.
In this thesis, I illustrate how complementary approaches from the physical and life
sciences can help confront this challenge. Specifically, I describe work that brings
together statistical mechanics and cell biology to shed light on how key regulators
of the adaptive immune system, T cells, are selected to enable pathogen-specific re-
sponses. A model of T cell development is introduced and analyzed (computationally
and analytically) by employing methods from statistical physics, such as extreme
value distributions and Hamiltonian minimization. Results show that selected T
cell receptors are enriched in weakly interacting amino acids. Such T cell receptors
recognize (i.e. bind sufficiently strongly to) pathogens through several contacts of
moderate strength, each of which makes a significant contribution to overall binding.
Disrupting any contact by mutating the pathogen is statistically likely to abrogate T
cell recognition of the mutated pathogen. We propose that this is the mechanism for
the specificity of T cells for unknown pathogens. The T cell development model is
also used to discuss one way in which host genetics can influence the selection of T
cells and concomitantly the control of HIV infection. A model of the T cell selection
process as diffusion in a random field of immobile traps that intermittently turn "on"
and "off" is developed to estimate the escape probability of dangerous T cells that
could cause autoimmune disease. Finally, and importantly, throughout this thesis,
I describe, how the theoretical studies are closely synergistic/complementary with
biological experiments and human clinical data.
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The immune system of an organism combats invading pathogens, thereby protecting
the host from disease. Jawed vertebrates, such as humans, have an adaptive immune
system that enables them to mount pathogen-specific immune responses (Janeway
et al., 2004). The importance of the adaptive immune response for human health is
highlighted by the opportunistic infections that afflict individuals with compromised
adaptive immune systems [e.g., those who have progressed to AIDS after infection
with the human immunodeficiency virus (HIV)]. The flexible adaptive immune system
can also go awry, and many diseases (e.g., multiple sclerosis and type I diabetes)
are the consequence of the adaptive immune system failing to discriminate between
markers of self and nonself. The suffering caused by autoimmune diseases and the
need to combat diverse infectious agents have motivated a great deal of experimental
research aimed toward understanding how the adaptive immune system is regulated.
These efforts have led to some spectacular discoveries (Allison et al., 1982; Chan
et al., 1992; Dialynas et al., 1983; Gallegos and Bevan, 2006; Hedrick et al., 1984;
Hogquist et al., 2005; Irving and Weiss, 1991; Unanue, 1984; Yanagi et al., 1984).
Yet an understanding of the principles that govern the emergence of an immune or
autoimmune response has proven to be elusive. The practical impact of this missing
knowledge is highlighted by the inability to design vaccines against many scourges on
the planet (e.g., HIV).
This chapter is based on the publication (Chakraborty and Kosmrlj, 2010).
An important barrier for the development of mechanistic principles that describe
adaptive immunity is that the pertinent processes involve cooperative dynamic events
with many participating components that must act collectively for an immune or
autoimmune response to emerge. Moreover, these processes span a spectrum of
timescales and length scales that range from interactions between molecules in cells to
phenomena that affect the entire organism; feedback loops between processes on dif-
ferent spatiotemporal scales are also important. It is often hard to intuit underlying
principles from experimental observations because of the complexity of these hierar-
chically organized collective processes. The importance of stochastic effects further
confounds intuition.
Statistical mechanics can relate observations to the underlying microscopic stochas-
tic events that occur in a complex interacting system. Statistical mechanical theory,
associated computations, and complementary experiments have therefore helped un-
cover mechanisms underlying complex physical and chemical phenomena. In this
thesis I describe work that brings together statistical mechanics and cell biology to
uncover new concepts in immunology. To properly define the problem, I begin with
a brief exposition of basic immunology.
1.1 Basic immunology
Higher organisms are constantly exposed to infectious microbial pathogens. Yet the
development of infectious diseases is relatively rare. This is because diverse types of
cells that compose the innate immune system are efficient in preventing pathogenic
microorganisms from establishing an infection. The components of the innate immune
system respond to common features of diverse pathogens, but are not specific for
individual pathogens. Some bacteria and many viruses can evade or overcome the
innate mechanisms of host defense. The adaptive immune system mounts pathogen-
specific immune responses against such invading microorganisms. Adaptive immunity
also establishes memory of past infections, thereby conferring the ability to mount
rapid immune responses to pathogens encountered previously. This immunological
memory is the basis for vaccination.
1.1.1 Two arms of the adaptive immune system
The adaptive immune system has two arms, called cellular and humoral immunity.
T lymphocytes (T cells) and B lymphocytes (B cells) are the key regulators of cellu-
lar and humoral immunity, respectively. T cells and B cells express immunoglobulin
proteins on their surfaces, which are called T cell receptors (TCRs) and B cell recep-
tors (BCRs), respectively. The genes encoding these receptors are inherited as gene
segments that stochastically recombine during the synthesis of T cells and B cells
in the bone marrow. Each gene assembled in a given lymphocyte is thus distinct,
enabling the generation of a great diversity of T cells and B cells expressing different
receptors. Different lymphocytes can potentially respond to specific pathogens as dis-
tinct receptors can potentially recognize (i.e., bind sufficiently strongly to) molecular
signatures of specific foreign invaders. Thus, the adaptive immune system can mount
pathogen-specific responses against diverse infectious microbes.
The diverse lymphocytes bearing different TCRs and BCRs that are generated in
the bone marrow by the stochastic recombination of gene segments do not all become
part of an organism's army of T cells and B cells that battle pathogens. Rather, T
cells and B cells undergo development processes that allow only a small fraction of
the generated cells to become part of an organism's repertoire of lymphocytes. T cells
develop in an organ called the thymus (the T stands for thymus). B cells develop
in the bone marrow (the B stands for bone marrow) and also, upon activation, in
lymphoid organs. The focus of this thesis is on studies aimed toward understanding
how developmental processes in the thymus shape the T cell repertoire such that
they exhibit both remarkable pathogen specificity and the ability to combat myriad
pathogens. To consider these issues, we note a few more biological facts.
1.1.2 What is recognition, where does it occur, and what do
T cells and B cells recognize?
Cells of the innate immune system (e.g., dendritic cells, macrophages) engulf pathogens
(also called antigens) present in different parts of an organism's body. These cells are
called antigen-presenting cells (APCs) because they express molecular signatures of
the ingested antigens on their surface. Extracellular fluid from tissues, which contains
pathogens or APCs harboring pathogens, drains into lymphoid organs (e.g., lymph
nodes, spleen) via the lymphatic vessels. The lymphatic vessels also enable lym-
phocytes to circulate among the blood, lymphoid organs, and tissues. In lymphoid
organs, lymphocytes can interact with pathogen-bearing APCs and pathogens and
recognize them as foreign. (We define the term recognize precisely below.)
If a lymphocyte recognizes pathogens in a lymph node, a series of intracellular
biochemical reactions occurs (called signaling) that results in gene transcription pro-
grams that cause the lymphocyte to become activated; i.e., it begins to proliferate
and acquire the ability to carry out functions that can mediate an immune response.
Activated lymphocytes thus generated, bearing receptors specific for the infecting
pathogen, then leave the lymph node and enter the blood via lymphatic vessels.
When they encounter the same pathogen's molecular markers in the blood or tissues,
they can carry out effector functions to eliminate the infection. For example, certain
kinds of activated T cells can kill cells infected by the pathogen, thereby killing the
pathogen as well.
The BCRs and TCRs expressed on B cells and T cells can bind to species that
are called ligands (Figure 1-1). B cells protect against pathogens in blood or extra-
cellular spaces. The ligands of the BCR include proteins, fragments of proteins, and
molecules on the surface of viruses or bacteria. T cells evolved to combat intracellu-
lar pathogens. Proteins synthesized by intracellular pathogens are cut up into short
peptide fragments by enzymes in cells harboring the pathogen. These peptide frag-
ments can potentially bind to protein products of the host's major histocompatibility
complex (MHC) genes. There are two kinds of MHC proteins, called MHC class I and
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Figure 1-1: Lymphocyte recognition of signatures of pathogens. (a) T cells (CTL-
cytotoxic T lymphocyte.). Antigen-presenting cells (APCs) engulf pathogens and
process their proteins into short peptides, which are bound to major histocompatibil-
ity complex (MHC) proteins and presented on the surface. T cell receptors (TCRs)
bind to peptide MHCs, and sufficiently strong binding enables intracellular signaling
and gene transcription, leading to T cell activation. APCs also present self-peptides
derived from self-proteins, but typically T cells are not activated by them. (b) B cells.
B cell receptors (BCRs) bind directly to antigens and their products, and sufficiently
strong binding results in productive intracellular signaling and internalization of the
antigen, bound to BCR. The antigen is processed by the B cell, which then presents
the corresponding peptide MHCs on its surface. Recognition of these peptide MHCs
by an activated T helper cell's TCR is usually necessary for B cell activation. This
figure is adapted from Figure 1 in (Chakraborty and Kosmrlj, 2010).
MHC class II. Typically, a human will have up to six types of MHC class I proteins,
and up to six types of MHC class II proteins. Pathogen-derived peptides (p) bound
to MHC proteins are ultimately expressed on the surface of APCs and infected cells.
These pMHCs are the TCR ligands.
When we say that a T cell recognizes a particular pathogen-derived pMHC, what
we mean is that its TCR binds to it sufficiently strongly, which allows productive
intracellular signaling and activation to occur. T cells activated by peptides presented
by MHC class II proteins proliferate and differentiate into many cell types called T
helper cells (for reasons noted below). T cells activated by peptides presented by






Figure 1-2: TCR recognition of pathogen-derived pMHC molecules is both highly spe-
cific and degenerate. It is specific because if a TCR recognizes a peptide (green), most
point mutations of the peptide's amino acids (red) abrogate recognition. However, a
given TCR can also recognize diverse peptides (green, blue, yellow).
CTLs encounter cells in tissues that express the pMHC molecules that originally
activated them, they can kill these cells by secreting various chemicals.
TCR recognition of pathogen-derived pMHC molecules is both highly specific and
degenerate (Figure 1-2). It is specific because if a TCR recognizes a pMHC molecule,
most point mutations of the peptide's amino acids abrogate recognition (Huseby
et al., 2005, 2006). However, a given TCR can also recognize diverse peptides (Eisen
and Chakraborty, 2010; Hemmer et al., 1998; Kersh and Allen, 1996; Misko et al.,
1999; Sloan-Lancaster and Allen, 1996; Unanue, 1984). This specificity-degeneracy
conundrum is made vivid by dividing the world of peptides into classes, with the
members of each class having sequences that are closely related. For example, peptides
within a class could differ by just point mutations. A TCR can discriminate quite
well between peptides within a class of closely related peptide sequences (as point
mutants of the peptides it recognizes are not recognized with high probability). But,
at the same time, TCRs are not so good at distinguishing between peptides with
different sequences as a given TCR can recognize many peptides. Understanding how
the TCR repertoire obtains these properties is the main focus of Chapter 2.
Similarly, when we say that a B cell recognizes a ligand, we mean that its BCR
binds sufficiently strongly to it, which results in signaling and also causes the inter-
nalization of the pathogen. pMHCs, with the peptide derived from the internalized
pathogen, are presented on the B cell surface. Signaling induced by the binding of
these class II pMHCs with a T helper cell's TCR (activated by the same pMHC)
augments BCR signaling to activate B cells. Activated B cells proliferate and dif-
ferentiate into plasma cells that secrete a soluble form of its BCR. These soluble
immunoglobulins are called antibodies. Antibodies act on pathogens in extracellular
spaces and in blood in a variety of different ways to help clear infections. Both T and
B cells also differentiate into memory cells that mount rapid immune responses upon
reinfection with the same pathogen.
The lymphocyte signaling network does not exhibit a continuous increase in re-
sponse as the stimulus (e.g., TCR-pMHC binding strength) is progressively increased.
Rather, it only responds strongly above a threshold stimulus level. This feature is
necessary for sharp discrimination between recognized and unrecognized ligands.
1.1.3 T cell development in the thymus gland.
After synthesis in the bone marrow, immature T cells (thymocytes) go to the thymus
(Figure 1-3; (Hogquist et al., 2005; Siggs et al., 2006; Starr et al., 2003; von Boehmer
et al., 2003; Werlen et al., 2003)), an organ located behind the sternum. Thymocytes
interact with a variety of self-pMHC molecules expressed on the surface of thymic
epithelial cells as well as hematopoietically derived macrophages and dendritic cells,
where self peptides are derived from diverse parts of the host proteome. For a T cell
to exit the thymus and become part of the host's repertoire of T cells, it must pass
the following two tests: (a) It must not be negatively selected. That is, its TCR
must not bind to any self-pMHC molecule with a binding free energy that exceeds
a threshold for negative selection. Such strong binding is likely to cause deletion of
the T cells. (b) It must bind at least one self-pMHC molecule with a binding free
energy that exceeds another threshold for positive selection. The negative selection
process aims to delete dangerous T cells, that could be activated by self pMHCs and
cause an autoimmune disease. The positive selection process ensures that TCRs of
Thymocyte Positive selection Mature T cell
Figure 1-3: Immature T cells (thymocytes) develop in the thymus. Thymocytes mi-
grate through the thymus and interact with diverse self peptide major histocompati-
bility complexes (self-pMHCs) presented on the surface of thymic antigen presenting
cells (APCs). A T cell's receptor (TCR) must bind to at least one of these self-pMHCs
weakly to exit the thymus and become a part of the individual's T cell repertoire (pos-
itive selection). A T cell with a TCR that binds to any self-pMHC with an affinity
that exceeds a sharply defined threshold dies in the thymus (negative selection). This
figure is adapted from Figure 3a in (Chakraborty and Kosmrlj, 2010).
selected T cells bind to MHC - this is called MHC restriction. Positively selected
T cells become part of an organisms' army that battle pathogens if they can avoid
negative selection.
1.2 Thesis outline
In this thesis, I present studies that enable an understanding of how the develop-
mental processes in the thymus shape the T cell repertoire such that adaptive immu-
nity exhibits both remarkable pathogen specificity and the ability to combat myriad
pathogens.
Chapter 2 sheds light on the specificity and degeneracy puzzle of the TCR recog-
nition of foreign peptides (Figure 1-2). In this chapter we develop a statistical me-
chanical model of the thymic selection process of T cells. Computational studies of
this model are used to characterize the properties of the selected T cell repertoire,
which are then used to describe the mechanism behind their specificity.
In Chapter 3, the model of thymic selection developed in Chapter 2 is analyzed
analytically by employing methods from statistical physics, such as extreme value
distributions and Hamiltonian minimization.
Chapter 4 investigates how some people are able to control the HIV infection
even without therapy. Genetic studies show that certain MHC types appear more
frequently in these people. This chapter discusses how some of these MHC types
may affect thymic selection, such that the statistical properties of the selected T cell
repertoire's characteristics provide one contributing factor for more efficient control
of HIV infection.
Chapter 5 was motivated by a question of the escape probability of dangerous T
cells from the thymus that can be activated by self peptides. Mimicking the thymic
selection, this chapter studies a problem of diffusion in a random field of immobile
traps that intermittently switch "on" and "off". The results of this study are used
to estimate the escape probability of dangerous T cells that can be activated by self
peptides.
The introduction and other chapters are based on published papers (Chakraborty
and Kosmrlj, 2010; Kosmrlj et al., 2008, 2009, 2010; Kosmrlj, 2011).
For the benefit of physicists not familiar with immunology, we present here a
glossary of immunological terms used throughout the thesis (Table 1.1).
Table 1.1: Glossary of immunological terms.
term description
antigen a foreign substance that induces an immune response in the
body
pathogen a bacterium, virus, or other microorganism that can cause
disease
APC antigen-presenting cell. They express molecular signatures
(peptides) of the ingested antigens on their surface.
peptide a short piece of protein presented to T cell receptors in a
groove of MHC proteins
HIV epitope a peptide derived from HIV proteins
immunodominant epitope that elicits the most significant response from the
epitope adaptive immune system
MHC major histocomplatibility complex. MHC proteins present
peptides to T cell receptors and are classified into classes I
and II.
HLA human MHC proteins
pMHC peptide-MHC complex
TCR T cell receptor. T cell receptors bind to pMHCs.
CDR loops TCR consists of 3 CDR loops. Highly variable CDR3 loop
binds to peptides and more conserved CDR1 and CDR2 loops
bind to MHC.
CD8+ T cell T cell receptors of those T cells bind to MHC class I proteins
CD4+ T cell T cell receptors of those T cells bind to MHC class II proteins
CTL cytotoxic T lymphocytes is CD8+ T cell. Activated CTLs kill
infected cells by secreting various chemicals.
T helper cell CD4+ T cell. T helper cells help activate B cells.
thymus gland An organ, where immature T cells are screened against self
peptide-MHCs.
thymocyte immature T cell that goes to the thymus
autoimmune dis- a disease caused by antibodies or lymphocytes produced
ease against substances naturally present in the body
alloreactivity The reaction between the immune cells of one individual and
the cells of another individual, e.g. the T cell response to
non-self MHC molecules.
Chapter 2
How the thymus designs
antigen-specific and self-tolerant T
cell receptor sequences?
T lymphocytes (T cells) orchestrate adaptive immune responses that clear pathogens
from infected hosts. T cells recognize short peptides (p) derived from antigenic pro-
teins bound to protein products of the MHC genes. Recognition occurs when T cell
receptor (TCR) proteins expressed on T cells bind sufficiently strongly to antigen-
derived pMHC complexes on the surface of antigen-presenting cells (Figure 1-la). A
diverse repertoire of self-pMHC-tolerant TCR sequences is shaped during develop-
ment of T cells in the thymus by processes called positive and negative selection. In
this Chapter we combine computational models and analysis of experimental data
to parse the contributions of positive and negative selection to the design of TCR
sequences that recognize antigenic peptides with specificity, yet also exhibit cross-
reactivity. A dominant role for negative selection in mediating antigen specificity
of mature T cells and a molecular mechanism for TCR recognition of antigen are
described.
Because T cell receptor (TCR) genes undergo stochastic somatic rearrangement,
most T cells express a distinct TCR, thereby enabling the T cell population to recog-
This chapter is based on the publication (Kosmrlj et al., 2008).
nize many different antigenic short peptide (p)MHC complexes. TCR recognition of
pMHC is both specific and degenerate (Figure 1-2). It is specific, because if a TCR
recognizes a particular pMHC complex, most mutations to the peptide amino acids
abrogate recognition (Huseby et al., 2005, 2006). It is degenerate because a given
TCR can interact productively with several antigenic peptides (Hemmer et al., 1998;
Kersh and Allen, 1996; Misko et al., 1999; Sloan-Lancaster and Allen, 1996; Unanue,
1984). pMHC complexes where the peptide is derived from the cell's own proteins
are also displayed on antigen-presenting cell (APC) surfaces. TCRs are self-tolerant
because they bind weakly to these "self" -pMHC complexes, thereby avoiding frequent
autoimmune responses.
The diverse, specific/degenerate, and self-tolerant T cell repertoire is designed
during T cell development in the thymus (Hogquist et al., 2005; Jameson et al.,
1995; Siggs et al., 2006; von Boehmer et al., 2003; Werlen et al., 2003). Immature T
cells (thymocytes) interact with a variety of self-pMHC molecules expressed on the
surface of thymic epithelial cells as well as hematopoietically derived macrophages and
dendritic cells. Thymocytes expressing a TCR that binds with high affinity to any
self-pMHC molecule are deleted in the thymus (a process called negative selection).
However, a thymocyte's TCR must also bind sufficiently strongly to at least one type
of self pMHC complex to receive survival signals and emigrate from the thymus (a
process called positive selection).
Signaling events, gene transcription programs, and cell migration during T cell
development in the thymus have been studied extensively (Borghans et al., 2003;
Bousso et al., 2002; Daniels et al., 2006; Detours et al., 1999; Detours and Perelson,
1999; Hogquist et al., 2005; Jameson et al., 1995; Scherer et al., 2004; Siggs et al.,
2006; von Boehmer et al., 2003; Werlen et al., 2003). Despite important advances,
how interactions with self-pMHC complexes in the thymus shape the peptide-binding
properties of selected TCR amino acid sequences such that mature T cells exhibit
their special properties is poorly understood.
Recent experiments carried out by Huseby et al. (2005, 2006) provided important
clues in this regard. These experiments determined differences in how T cells interact
with foreign (antigenic) pMHC depending on whether they developed in conventional
mice that display a diverse array of self-pMHC complexes in the thymus or if they
develop in mice that were engineered to express only one type of peptide in the
thymus. For T cells that develop in conventional mice, T cell recognition of antigenic
pMHC was found to be sensitive to most mutations of the antigenic peptide's amino
acids. In contrast, T cells selected in mice with only one type of peptide in the
thymus were much more peptide-degenerate, with some T cells being tolerant to
most mutations of antigenic peptide amino acids.
We reasoned that a detailed understanding of the origin of these experimental
results may shed light on the broader question of how the thymus designs diverse
self-tolerant TCR sequences that mediate specific/degenerate antigen recognition.
Toward this end, we studied a computational model of thymic selection.
2.1 Thymic selection model
To describe the interactions between TCRs and pMHC complexes, we represent them
as strings of sites (Figure 2-1). Each site on a TCR can interact with the corresponding
site on a pMHC molecule. Such string models for studying TCR pMHC interactions
have been used to study various issues, including thymic selection (Chao et al., 2005;
Detours et al., 1999; Detours and Perelson, 1999), and employed simplified represen-
tations of amino acids (e.g., a string of numbers, bits, etc.). From the standpoint of
our work, the most pertinent result revealed by these past studies are calculations
showing that negative selection reduces TCR cross-reactivity. The mechanistic rea-
sons underlying this numerical result or how it relates to amino acid sequences of
selected TCRs were not described. The goal of this Chapter is to elucidate how the
diversity of endogenous peptides bound to host MHC proteins encountered in the
thymus determines the amino acid sequences of peptide contact residues on selected
TCRs and how such TCRs are antigen specific while also being cross-reactive and
self-tolerant.




Figure 2-1: Schematic representation of the interface between TCR and pMHC com-
plexes. The CDR3 loop segment of TCR that is in contact with peptides is highly
variable and modeled by a string of N amino acids. The peptide is also modeled by a
sequence of length N, and the binding free energy is computed as a sum of pairwise
interactions. We do not explicitly consider TCR sites (CDR1 and CDR2 loops) in
contact with MHC, as they are more or less conserved, and only assign them a net
interaction free energy Ec. This figure is adapted from Figure 3b in (Chakraborty
and Kosmrlj, 2010).
relate the results closely to known experimental data such as that of Huseby et al.
(2005, 2006). Because Huseby et al. used transgenic mice that expressed a single
type of MHC, we divided the string of sites on the pMHC molecule into a conserved
part representing the MHC and a variable part representing the peptides. One could
also view the variable sites more generally as representative of the peptides and the
variable residues of the MHC. The CDR1 and CDR2 loops of the TCR mostly contact
MHC residues, whereas the CDR3 loop primarily contacts the peptide residues. We
partitioned the TCR interaction sites into two parts: a region representing the CDR1
and CDR2 loops and a part that mimics the CDR3 loop. Because the CDR3 loops
are hypervariable, the amino acids of the peptide contact residues of the CDR3 region
are explicitly considered, whereas those of the less variable CDR1 and CDR2 regions
are not (Figure 2-1). For ease of reference, the CDR3 sites are called, variable. These
variable sites represent only those CDR3 amino acids that contact peptide amino
acids (or variable MHC residues). Thus, we do not explicitly treat the conformation
CDR 1,2 *CDR 1,2
Table 2.1: Amino
genes proteomes.
acid frequencies of Homo sapiens, mouse and Listeria monocyto-
amino Homo Mus musculus Listeria
acid sapiens (house mouse) monocytogenes
A 0.0692 0.0681 0.0774
C 0.0225 0.0228 0.0061
D 0.0476 0.0481 0.0544
E 0.0718 0.0700 0.0744
F 0.0359 0.0369 0.0453
G 0.0658 0.0641 0.0667
H 0.0261 0.0263 0.0178
I 0.0434 0.0439 0.0784
K 0.0576 0.0576 0.0716
L 0.0985 0.0993 0.0951
M 0.0215 0.0221 0.0275
N 0.0360 0.0358 0.0462
P 0.0636 0.0619 0.0347
Q 0.0481 0.0479 0.0346
R 0.0568 0.0563 0.0365
S 0.0836 0.0850 0.0580
T 0.0536 0.0541 0.0611
V 0.0598 0.0609 0.0704
W 0.0123 0.0120 0.0093
Y 0.0263 0.0269 0.0345
of the CDR3 loop, which would be necessary if the entire sequence of CDR3 amino
acids was considered. Similarly, because peptides bound to MHC are short, peptide
conformation is not an important variable. Although we vary the peptide length
(data not shown), most results we present in this Chapter are for peptides that are
10 amino acids long1 .
We generate panels of TCR and self pMHC molecules on the computer by picking
amino acids for the peptides and peptide contact residues on the CDR3 loops of the
TCR according to the probabilities with which amino acids appear in the human (or
mouse) proteome (Table 2.1 and (Flicek et al., 2008; Kosmrlj et al., 2008)). Antigenic
'The number of contacts between a TCR and a peptide is ~ 5 and in next Chapters we are using
sequences of length 5 amino acids. The qualitative results presented in this chapter do not depend
on the choice of the sequence length (Chapter 3).
peptides are generated using the frequency of occurrence of amino acids in Listeria
monocytogenes, a common bacterial pathogen (Table 2.1 and (Kosmrlj et al., 2008;
Moszer et al., 1995)). To assess the effects of thymic selection as well as antigen
recognition, we evaluate the free energy of interaction between TCR-pMHC pairs.
The interaction free energy between the CDR1 and CDR2 regions of TCRs and the
MHC is given a value equal to Ec (and it is varied to describe different TCRs). The
total interaction free energy equals the sum of Ec and the value obtained by aligning
the TCR and pMHC amino acids that are treated explicitly by adding the pairwise
interactions between corresponding amino acids. For a given TCR-pMHC pair, the
total interaction free energy is
N
Ent (tl S) = Ec + J(tiI si), (2.1)
i=1
where Ec is defined above, and J(ti, si) is the interaction free energy between the ith
amino acids on the variable part of the TCR (ti) and the peptide (si), respectively,
and N is the length of the variable regions. The matrix J encodes the values of
interaction energies between specific types of amino acids. For most results presented,
J was taken to be the parameterized potential due to Miyazawa and Jernigan (MJ
matrix) which has been used fruitfully to study proteins (Li et al., 1997; Miyazawa
and Jernigan, 1996). However, we also used other potentials (vide infra), including
ones where the interaction between a pair of juxtaposed amino acids depends on the
neighboring residues, to show that our qualitative results and mechanistic insights are
independent of this choice (see Figures A-1 - A-4). We express free energy values in
units of the thermal energy, kBT, where kB is Boltzmann's constant, and T = 370 C is
room temperature, at which the thermal energy equals 0.6 kcal mol-1. We emphasize
that the purpose of our study is not to compute specific values of energies but to use
them to obtain qualitative mechanistic insights.
Recent experiments show that negative selection occurs when the TCR-pMHC in-
teraction affinity exceeds a sharply defined threshold (Daniels et al., 2006). Because
affinity correlates directly with the free energy gained upon binding, in our model, if
the interaction free energy, Eint, between a TCR and self-pMHC is more attractive
than (exceeds) a threshold value (|Einel > |Eal), this TCR is negatively selected. It
is possible that the off-rate characterizing TCR-pMHC binding, rather than affinity,
determines ligand potency, and, indeed, ligands that induce positive and negative se-
lection are separated by a sharp boundary in off-rate as well. Off-rate correlates with
the free-energy barrier associated with dissociation of the TCR-pMHC complex. For
a related set of reactions, this barrier and the binding free energy scale similarly (Ed-
wards, 1954; Swain and Scott, 1953) and so use of the interaction free energy should
correlate with trends in off-rate as well2 . The ability of a pMHC ligand to stimulate
positive selection does not go to zero abruptly (Daniels et al., 2006). In our model, if
the interaction free energy between a particular TCR-pMHC pair exceeds a threshold
value, E,, the TCR is positively selected. Replacing the soft threshold associated with
positive selection with a sharp boundary does not affect qualitative results (Figure A-
5) because we find that the characteristics of peptide binding residues on selected T
cells are largely shaped by negative selection. The effects of varying E, and E, over
wide ranges are described in the context of our results.
2.2 Selection against many self-pMHC molecules
is required for antigen-specific TCR sequences.
We first tested whether our computational model could recapitulate the experimental
observation (Huseby et al., 2005, 2006) that T cell recognition of an antigenic peptide
is sensitive to mutations at many peptide sites for T cells selected against many
endogenous thymic peptides, whereas very few sites on the antigenic peptide are
important for recognition for T cells selected in mice that express one type of peptide
2 The relationship between the change in free energy at equilibrium (related to affinity) and the
free energy barrier for the reaction to occur (related to off-rate) for a set of related reactions has
been studied extensively. Reactions are considered related if the change from one reaction to another
is a change in some moieties that does not change the class of reactions (e.g. reactions of amines
(-RNH2 ) with an acid and varying R groups). For related reactions, the free energy surfaces usually
do not intersect. As such, if the equilibrium free energy change is larger for one reaction compared
to another, then so is the free energy barrier. Thus, the reaction with the higher affinity will also
have a lower off-rate. These relationships are called linear free energy relationships.
in the thymus.
For a specific choice of the interaction energy between the CDR1/CDR2 region
of the TCR and the MHC (Ec), a panel of one million sequences of TCR peptide
contact residues was generated by choosing different amino acids for the variable
region according to the frequency with which they appear in the human proteome
(results for mouse are in Figure A-6). In the case where there was only one type of
self pMHC complex in the thymus, the interaction energy between each TCR and a
MHC-bound peptide moiety representative of the human proteome was computed by
using the MJ interaction energy matrix and Equation (2.1). Only those TCRs that
have interaction energies lying between the positive- and negative-selection thresholds
were selected (|E,I < |Einl < Er, ). The selected T cells were then challenged with
many antigenic peptides characteristic of L. monocytogenes (Table 2.1 and (Kosmrlj
et al., 2008; Moszer et al., 1995)). A TCR was considered to recognize an antigenic
pMHC if the interaction free energy exceeded the recognition threshold, |Eint| >
|Erl. Experimental evidence (Naeher et al., 2007) suggests that the negative selection
threshold in the thymus is the same as recognition threshold in the periphery, i.e.
E, = Er,. In this way, panels of selected T cells that recognize different antigens were
generated. Each amino acid on the antigenic peptides was then mutated to the 19
other possibilities, and recognition by the reactive TCRs was again assessed. If more
than half the mutations at a particular amino acid site led to abrogation of recognition
for an originally reactive T cell, the site was labeled an "important contact". This
procedure was repeated 1,000 times with a different panel of preselection TCRs, and
choices for the peptide in the thymus and antigenic peptides to obtain statistics on the
number of important contacts characterizing interactions between a typical antigenic
peptide and selected TCRs.
For many types of peptides in the thymus, we generated a panel of 10,000 self-
peptides using amino acid frequencies characteristic of the human proteome (Ta-
ble 2.1 and (Flicek et al., 2008; Kosmrlj et al., 2008)). The results we obtain are
qualitatively robust if at least 100 types of pMHC complexes are in the thymus (Fig-
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Figure 2-2: Cartoon representation of the three regimes of values of TCR-MHC inter-
actions (Ec). In these regimes the TCR-MHC interactions are (i) weak, (ii) strong,
and (iii) moderate compared with the threshold for negative selection, E,,. This figure
is adapted from Figure lb in (Kosmrlj et al., 2008).
of all thymocytes. Interaction free energies of the panel of TCRs with self-pMHCs
were calculated. A TCR was positively selected if it interacted with at least one
such pMHC with a free energy that exceeded the positive-selection threshold (Ep).
To avoid negative selection, a TCR must not interact with any self-pMHC with a
free energy that exceeds the negative selection threshold (E"). Important contacts
characterizing antigen recognition were determined in the manner described above.
Although the interaction energy between the CDR1 and CDR2 regions of the
TCR and MHC (Ec) varies continuously as residues on the CDR1 and CDR2 regions
change, TCRs can be grouped into three classes based on the relative values of Ec
and the negative-selection threshold, E, (Figure 2-2): (i) TCR-MHC interactions are
very weak (Ec and E, are separated by a large value); (ii) TCR-MHC interactions are
very strong (Ec and E, are separated by a small value); (iii) TCR-MHC interactions
are moderate in scale (Ec and E, are separated by a moderate value). Based on
recent experimental data (Daniels et al., 2006), for results reported, the difference
between E, and E, is taken to be relatively small (5kBT).
Very few preselection TCRs with CDR1 and CDR2 loops that interact very weakly
with conserved MHC (case i) are positively selected if E, and E" are relatively close.
In effect, they are not MHC restricted. These TCRs are irrelevant for our studies of
how thymic selection shapes antigen-specific peripheral T cells. TCRs with CDR1
and CDR2 loops that interact very strongly with MHC (Ec close to or greater than
E, case ii) are negatively selected with very high probability and so are not relevant
for our studies of understanding the origin of how thymic selection results in antigen
specificity in the periphery. Not surprisingly then, our studies focus on TCRs with
values of Ec that correspond to moderate interactions between the CDR1/CDR2 loops
and MHC (case iii). These TCRs are positively selected with high probability and
must avoid negative selection to emerge into the periphery. The particular value3
of E, - Ec = -40kBT is chosen such that the negative selection deletes - 80%
of positively selected TCRs, when they are selected against many self peptides (van
Meerwijk et al., 1997; Merkenschlager et al., 1997). It is enough to study only a single
value of TCR binding strength to MHC (Ec), because a moderate changes in Ec value
do not change the qualitative results (Figure A-7). Therefore having a distribution
of TCR binding strengths to MHC also wouldn't change the qualitative results.
Figure 2-3 shows the frequency of important contacts resulting from our calcula-
tions when the conserved TCR-MHC interactions are moderate in scale (E, -Ec taken
to be -40kBT for the results). For TCR selected against many types of peptides,
a large fraction of the antigenic peptide's amino acid sites are important contacts.
In contrast, when TCR are selected against one type of peptide in the thymus, very
few antigenic peptide amino acid sites are important contacts. This mirrors previ-
ous experimental observations (Huseby et al., 2005). We also find that for moderate
TCR-MHC interactions, the ability of T cells to mature when only one type of pep-
tide is present in the thymus is limited by positive selection, whereas T cell survival
is limited by negative selection when there are many types of peptides in the thymus
3 A rough estimate on the bounds of Ec values of selected TCRs can be obtained without fitting
from the condition that the average interaction free energy between TCR and pMHC for selected
TCRs is between the thresholds for positive and negative selection E" < Ec + NJ < Ep, where J is
the average value of interaction between amino acids. The upper (lower) bound Ec,max = Ep - NJ =
-30.5kBT (Ec,min = E, - NJ = -35.5kBT) ensures that, on average, interactions result in positive
selection and not negative selection. Since for the selection it is enough that a TCR sequence is
positively selected by one of many self peptides and avoid being selected by all self peptides the
actual bounds for Ec might be different, but we expect that the range of Ec values will still be small;
viz. Ec,max Ec,min oc E, - En.
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Figure 2-3: Selection against many peptides in the thymus results in a larger number
of important contacts characterizing antigen recognition. The frequencies of occur-
rence of one, two, three, etc., important contacts (defined in text) on MHC-bound
antigenic peptide moieties recognized by selected TCRs. For TCRs that develop in
a thymus with many types of self-peptides (blue curve, M = 10, 000 peptides) many
sites on the antigenic peptide moiety are important contacts. For TCRs that develop
in a thymus with only one type of self-pMHC complex (black curve, M 1 peptide)
there are far fewer important contacts, indicating less specific (more degenerate or
cross-reactive) recognition. This figure is adapted from Figure ic in (Kosmrlj et al.,
2008).
(Figure A-9). Because our computational model recapitulates known experimental
data (Figure 2-3 and references (Huseby et al., 2005, 2006)), we used the model to
obtain insights into the mechanistic origins of antigen specificity.
2.3 Frustration during negative selection strongly
constraints selected TCR sequences.
For a TCR to emerge from the thymus when only one type of pMHC complex is
present therein, the binding free energy of the TCR for this pMHC must lie in the
interval between E, and E,. Because the interaction free energy between the TCR's
peptide contact residues and the peptide's amino acids is a sum over individual con-
tact free energies (Equation 2.1), many sequences of peptide contact residues on the
TCR can satisfy this criterion. A type of selected sequence that occurs with high prob-
ability is one where a small number of TCR residues make strong contacts with the
corresponding peptide amino acids, and all of the others make irrelevant (i.e., weak)
contacts (Figure 2-4). A TCR with such a sequence of peptide contact residues on
the TCR would almost certainly be negatively selected when many types of peptides
are present in the thymus. This is because it will likely encounter another peptide
in the thymus that can differ by only a single amino acid, leading to an additional
significant interaction and a total free energy that exceeds E,.
Thus, surviving negative selection presents a frustrating situation because a TCR
that avoids negative selection with one peptide in the thymus could be negatively se-
lected by another peptide. Positive selection does not present this problem because,
once a TCR receives survival signals by binding a single peptide more strongly than
E,, interactions with other peptides are only relevant for negative selection. The frus-
tration associated with subsequently avoiding negative selection by all these diverse
pMHCs is the dominant constraint determining peripheral TCR sequences.
To explore how this frustration influences the character of the peptide contact
residues of selected TCRs, we developed an analytical approximation (Chapter 3) that
suggested that the peptide contact residues on selected TCRs are greatly enriched in




Figure 2-4: Schematic description of frustration due to negative selection. The thick-
ness of the bars (or color of peptide amino acids: strong, red; moderate, blue; weak,
yellow; very weak, green) is proportional to the interaction energy between TCR and
pMHC residues. When developing in a thymus with only one type of endogenous
peptide, a TCR that results in a few strong interactions and several weak or mod-
erate interactions with this peptide can survive selection. This is because the total
interaction energy falls between the positive- and negative-selection thresholds. The
TCR shown in this figure, that survives selection against one type of peptide in the
thymus, would likely be negatively selected when there are many types of peptides in
the thymus. For example, a peptide that differs by one amino acid from the first one
(shown as a change from green to blue colored amino acid) may lead to an additional
moderate interaction energy that is sufficient to increase the total interaction energy
past the negative selection threshold.
2.4 Negative selection against many self peptides
results in TCR sequences with peptide contact
residues enriched in weakly interacting amino
acids.
To test this suggestion, we first examined the amino acid compositions of the pep-
tide contact residues of the selected TCRs obtained from our computer simulations.
When there are many types of peptides in the thymus, peptide contact residues of se-
lected TCRs are enriched in amino acids that interact weakly with other amino acids,
whereas strongly interacting amino acids and amino acids with flexible side chains are
attenuated (Figure 2-5a). The opposite is true when T cell selection is mediated by a
single peptide species in the thymus, with preferential selection of TCR that contain
strongly interacting amino acids. In Figure 2-5a, amino acids were ordered according
to the maximum value of the strength with which each amino acid interacts with all
others. The nature of the MJ interaction potential is such that this order also reflects
the ordering obtained by considering the average value of the interaction free energy
of an amino acid with all others. The qualitative results shown in Figure 2-5a are
robust to changes in the interaction potential (Figures A-1 - A-4 and Chapter 3).
Using different potentials only changes the identities of the amino acids that interact
weakly or strongly or the criterion used to define interaction strength. For example,
if a potential is such that the order of amino acids obtained by using the average in-
teraction free energies with other amino acids is quite different from that obtained by
considering the largest interaction free energies, the qualitative results in Figure 2-5a
are obtained if we use the latter quantities to order amino acids.
Do experimental data support our conclusion that frustration due to negative
selection skews the mature T cell repertoire to TCRs composed of peptide contact
residues enriched in amino acids that bind weakly to other amino acids? We analyzed
the 18 available crystal structures of TCR bound to class I pMHC complexes to obtain
the frequency with which different amino acids are represented at residues of the TCR
that contact the peptide (Kaas et al., 2004). All TCR moieties that contact peptide
amino acids were considered, and two methods were used to identify these contact
residues. One was to define a contact as a position where a water molecule does not
fit in the gap between a TCR residue and a peptide amino acid. In the other method,
residues in contact have their C, atoms within 6.5 A of each other. The qualitative
results are the same for both methods (Figure A-10), and in Figure 2-5b, we show
results using the second criterion.
Whereas the qualitative computational results (Figure 2-5a) are independent of
interaction potential, to compare the experimental data with this prediction, we need
to know whether a particular amino acid is weak or strong in reality. We have used
two different prescriptions to order the amino acids according to the strength of their
interactions with other amino acids. One is to use the MJ matrix, but the order
thus obtained has been criticized because it overemphasizes hydrophobic interactions
and considers interactions between charged amino acids to be weak (Sorenson and
a33
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Figure 2-5: Selection against many types of peptides in the thymus results in selected
TCRs with peptide contact residues with an enhanced frequency of amino acids that
interact weakly with all other amino acids. The ordinate is the ratio of the frequencies
of occurrence of an amino acid in the peptide contact residues of selected TCRs
to preselection TCRs. (a) For the computational results, the abscissa is a list of
amino acids ordered according to the maximum free energy (as per the MJ interaction
potential) with which it interacts with all other amino acids. The qualitative results
are robust to changes in potential (Figures A-i - A-4). (b) The ordinate was obtained
by analyzing the 18 available crystal structures of TCR-pMHC (class I) complexes as
described in the text. Amino acids were classified as strongly interacting (IVYWREL)
or weakly interacting (QSNTAG) following the reference (Zeldovich et al., 2007). This
figure is adapted from Figure 2 in (Kosmrlj et al., 2008).
Head-Gordon, 1998). Data obtained by examining the stability of thermophiles are
proposed to be better suited for analyzing the strength of interactions between amino
acids (Zeldovich et al., 2007), and posit that the strongly interacting amino acids are
IVYWREL, and the weakly interacting ones are QNSTAG (Zeldovich et al., 2007).
Figure 2-5b shows results where amino acids are divided into two classes (weak
and strong) according to this prescription. The data obtained from crystal structures
are in qualitative agreement with the theoretical prediction in that weakly interact-
ing amino acids are enriched on peptide contact residues of the TCR, and strongly
interacting amino acids are attenuated. Using the MJ matrix leads to similar results
(Figure A-10), except that charged amino acids (R, E, K), which are weak according
to the MJ matrix, are additional outliers. Tyrosine is considered to be a strongly in-
teracting amino acid by either approach, but is well represented in the TCR-peptide
contact residues. This may be because a germ-line-encoded tyrosine interacts with
a conserved MHC residue that is close to the peptide amino acids (Dai et al., 2008;
Feng et al., 2007), and so it may interact ubiquitously with peptide amino acids.
Our results suggest that negative selection against many types of thymic peptides
results in mature TCRs with peptide contact residues that interact weakly with other
amino acids. How does this influence their antigen specificity?
2.5 Antigen specificity is the result of TCR residues
binding peptides via multiple moderate inter-
actions.
In our model, the interaction energy between an antigenic peptide and residues of
a TCR that recognizes it is the sum of 10 numbers, with each number being the
interaction energy between an amino acid on the peptide and the corresponding TCR
contact site (Figure 2-1). We computed the values of these site-site interaction en-
ergies using all our TCR-antigenic peptide pairs. In Figure 2-6, we compare the
frequency with which each value of these interaction energies occurs for three cases:
preselection TCRs, TCRs that developed in a thymus with many types of pMHC,
and TCRs that developed in a thymus with one type of pMHC.
Our results indicate that, compared with the preselection TCRs, antigen recog-
nition by TCRs selected against many types of pMHC complexes is mediated by
fewer strong and weak amino acid-amino acid interactions, resulting in a pronounced
enhancement of moderate interactions. This result is consistent with experimental
observations of Savage and Davis (2001). This focusing on moderate interactions
is because negative selection constrains mature TCR peptide contact residues to be
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Figure 2-6: Distribution of amino acid-amino acid contact energies (in units of kBT,
described in text) characterizing interactions between selected reactive TCRs and
antigenic peptides suggest the basis for specificity. The distribution of interaction
energies between individual amino acids on peptide contact residues on the TCR
and antigenic peptides are shown. The distribution for TCRs that develop in a
thymus with many endogenous peptides (blue curve) is very different from that for
preselection TCRs (red curve). The distribution of contact energies is not significantly
altered for TCRs that develop in a thymus with only one type of peptide (black curve)
compared with preselection TCRs. This figure is adapted from Figure 3 in (Kosmrlj
et al., 2008).
TCRs can only recognize, i.e. bind sufficiently strongly to, antigenic peptides that
are composed of predominantly strongly interacting amino acids and amino acids with
flexible side chains (Figure 2-7a). To test this experimentally, we analyzed amino acid
frequencies in a list of best known HIV peptides (Llano et al., 2009) and compared
them to amino acid frequencies in HIV proteome (Belshaw et al., 2009). Figure 2-7b
shows that HIV peptides are indeed enriched with strongly interacting amino acids.
Thus the weakly interacting amino acids on the TCR bind to strongly interacting
amino acids on antigenic peptides resulting in multiple moderate scale interactions
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Figure 2-7: Amino acid frequencies of recognized antigenic peptides are enriched with
strongly interacting amino acids. (a) For the computational results, the ordinate
shows is the ratio of amino acid frequencies of antigenic peptides that are recognized
by at least one of the selected TCRs with respect to amino acid frequencies of all
antigenic peptides. The black curve depicts the results for TCRs selected against
one self-peptide (M = 1), whereas the blue curve corresponds to selection against
many self peptides (M = 10, 000). The amino acids on the abscissa are ordered from
strongest (L) to weakest (K) according to the strongest interaction with another amino
acid in the MJ matrix. (b) The ordinate was obtained by analyzing a list of the best
known recognized HIV peptides (Llano et al., 2009) and the HIV proteome (Belshaw
et al., 2009). Amino acids were classified as strongly interacting (IVYWREL) or
weakly interacting (QSNTAG) following the reference (Zeldovich et al., 2007).
that add up to a total binding free energy that is large enough for recognition. Be-
cause antigen recognition is mediated by multiple interactions of moderate value,
each contact makes a significant contribution to the total interaction free energy nec-
essary for recognition. Therefore, disrupting any interaction by mutating one of the
strongly interacting amino acids on the peptide results in abrogation of recognition
(Figure 2-8). This is the origin of antigen specificity. This prediction is consistent
with measurements reported for the B3K 506 TCR, which was selected against many
types of pMHC complexes in the thymus and recognizes the 3K-IAb pMHC (Huseby











Figure 2-8: Mechanism for specificity and degeneracy of TCR recognition of antigenic
peptides. The weakly interacting amino acids (green) on the TCR bind to strongly
interacting amino acids (red, blue) on antigenic peptides resulting in multiple moder-
ate scale interactions that add up to a total binding free energy that is large enough
for recognition. Because antigen recognition is mediated by multiple interactions of
moderate value, each contact makes a significant contribution to the total interaction
free energy necessary for recognition. Therefore, disrupting any interaction by mu-
tating one of the strongly interacting amino acids on the peptide results (shown as a
change from red to yellow color) in abrogation of recognition. At the same time TCR
recognition of antigenic peptides is degenerate, because there are many combinatorial
ways of distributing strongly interacting amino acids (red, blue) along the peptide,
which results in a sufficiently strong binding with TCR for recognition.
values, and each contributes significantly to recognition. At the same time TCR
recognition of antigenic peptides is degenerate, because there are many combinatorial
ways of distributing strongly interacting amino acids along the peptide, which results
in a sufficiently strong binding with TCR for recognition (Figure 2-8). TCRs that
survive negative selection against many types of peptides are quite diverse because
many sequences are consistent with the constraint that peptide contact residues are
predominantly composed of amino acids that interact weakly with all others.
When there is one type of pMHC complex in the thymus, the peptide-binding
residues of selected TCRs are not subject to the important constraints of avoiding
negative selection against many types of peptides, and moderate amino acid-amino
acid interactions do not dominate (Figure 2-6). Figure 2-5a suggests that strongly in-
teracting amino acids are represented more than in the preselection repertoire. How-






against many self peptides. If we allow the distribution of Ec values, the TCRs that
bind more strongly to MHC (larger |Ecl values) may also survive the thymic selection
against only one type of self peptide (Figure A-9) and such TCRs have a lower fre-
quency of strongly interacting peptide contact residues (see Chapter 3 and Figure A-
7). Therefore, sufficiently strong binding of TCR for antigenic peptide recognition
may be reached by a few strong interactions and by stronger binding to MHC. Thus,
mutating the antigenic peptide amino acids that contact strongly interacting amino
acid residues on the TCR should abrogate recognition, but mutations at most other
sites should have little impact. This is reflected in the experimental data reported
by Huseby et al. (2006). For one example, consider the YAe62.8 TCR, which is se-
lected against a single type of peptide in the thymus and recognizes variants of the
3K-IAb antigenic peptide. Most mutations to the antigenic peptide result in small
changes in AAG, but one mutation results in a large change. This one major peptide
contact dominates the interaction free energy with the others being irrelevant, and
this is the origin of enhanced cross-reactivity. It may also happen that the binding
free energy between a TCR and antigenic peptide is sufficiently strong that a sin-
gle mutation of peptide amino acids cannot prevent recognition, which results in 0
important contacts (Figure 2-3).
2.6 Escape of T cells, which could trigger an au-
toimmune disease
Thymic selection is not perfect and it may happen that some TCRs, which interact
strongly with self pMHCs, escape from the thymus. Such TCRs could potentially lead
to development of autoimmune disease, and in the remainder of this Chapter they
are labeled as "autoimmune" TCRs. Due to stochastic effects, it may happen that a
diffusing T cell in the thymus never interacts with some peptides that would lead to
negative selection (see Chapter 5). It may also happen that the negative selection is
not perfect, i.e. even if a TCR binds strongly to self-pMHC it can escape with some
probability. Here we only focus on the latter effect, which can be modeled with a soft
threshold for negative selection. For a TCR rthat interacts with self peptide ', the
probability of negative selection is assumed to be
1
Pn (t 1 1 + exp -(Eint (,s') -En (22
0-n
where the parameter or, denotes the softness of negative selection threshold. For
a TCR that interacts strongly with self-pMHC (JEint| > |Enl), the probability of
negative selection is close to 1, while for a TCR that interacts weakly with self-
pMHC (|Eint| < |Enl) the probability of negative selection is small. Similarly we
can define the probability for positive selection P, with the corresponding softness
o-,. From experiments (Daniels et al., 2006) we know that the threshold for positive
selection is softer (u, > Orn).
In this casethymic selection is modeled by testing each TCR sequence with all self-
pMHCs: for each self-peptide we calculate the corresponding probabilities Pp and P,
of positive and negative selection, then we draw two uniformly distributed random
numbers r, and rn on the (0, 1) interval and a TCR is positively (negatively) selected if
r, < P (r, < Pa). After thymic selection is completed, we check if any of the selected
TCRs interacts strongly with any self-peptide (|Eintl > |E.). Deterministic criteria
are now used because strong interaction free energy leads to high probability of T
cell activation. Any other deterministic or stochastic criteria would not qualitatively
change the results. We find that the introduction of soft thresholds for positive and
negative selection does not qualitatively change the results reported in the first part
of this chapter (Figure A-5).
Figure 2-9a shows that increasing the softness of the threshold for negative selec-
tion 07n, increases the chance of escape of autoimmune TCRs. This is because strongly
interacting TCRs are negatively selected with lower probability when threshold for
negative selection is softer. Interestingly the ratio of the numbers of autoimmune T
cells to the number of selected T cells seem to be roughly constant with the number M
of self-peptides used during the development in thymus (Figure 2-9b). The fraction of
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Figure 2-9: Ratio of the numbers of escaped autoimmune TCRs and selected TCRs as
a function of: (a) the softness of threshold for negative selection o-n, (b) number of self
peptides M. The fraction of autoimmune TCRs increases with or, until the softness
of the thresholds becomes of the same order as the separation between the thresholds
of positive negative selection, o- + o-, ~ |E, - E,|. The errorbars in (a) and (b)
correspond to the standard deviation of the fractions of escaped TCRs obtained from
repeating the thymic selection process many times. (En - Ec = -21kBT, E, - E=
-2.5kBT, N = 5, M = 1,000, o-= 0.1kBT, ~, = IkBT).
autoimmune T cells first increases for small M, but then it becomes roughly constant.
This may be because the T cell repertoire properties in the EVD calculation scale as
v/ln M (see Chapter 3). Note that with increasing number of self-peptides M, both
the number of autoimmune T cells and the number of selected T cells decreases, but
the ratio is roughly constant. While this ratio is roughly independent of M in the
relevant regime (M - a few thousands, Figure 2-9b), the absolute numbers of escaped
autoimmune T cells is higher for smaller M. This implies that the rate for escape
of autoimmune T cells could be higher in people expressing MHCs that bind fewer
types of self peptides. This may be why people expressing HLA-B57 that binds ~2-3
times fewer self peptides, and are better at controlling HIV infection (see Chapter 4),
are also more prone to autoimmunity.
Experimental results show that the escape of autoimmune TCRs is higher in
humans compared to mice, and the results of Figure 2-9a suggest that this may be
due to the differences in the softness of threshold for negative selection.
2.7 Conclusions
Although important clues were provided by the experimental data reported by Huseby
et al. (2005, 2006), a mechanistic understanding of how thymic selection designs TCR
sequences that are simultaneously antigen specific, cross-reactive, diverse, and self-
tolerant remained unclear. Our computational studies shed light on these issues.
If a TCR receives survival signals from a self-pMHC complex, it is positively
selected. Interactions with the other peptides expressed in the thymus are then only
relevant for negative selection. Positive selection ensures MHC restriction, enables
weak binding of TCRs to self pMHC, and influences the fraction of T cells that
survive thymic selection. Thus, it mediates important properties. However, antigen
specificity appears to be determined by the requirement that positively selected T
cells must survive negative selection.
TCR sequences must simultaneously avoid being negatively selected by many
endogenous MHC-bound peptides, and this imposes strong constraints on the nature
of the peptide contact residues of selected TCRs. We find that this is why, in mature T
cells, these residues are enriched in amino acids that interact weakly with other amino
acids (referred to as weak amino acids). For a selected TCR to recognize an antigenic
peptide in the periphery, it must bind to it with an affinity that exceeds a threshold.
This can occur only if the peptide is composed of amino acids that are among the
strongest binders of the corresponding weak amino acids of the TCR's peptide contact
residues (Figure 2-7), resulting in a number of moderate scale interactions that sum
up to exceed the threshold affinity required for recognition. Because each moderate
interaction contributes a substantial fraction of the overall affinity, disrupting most
of them (via mutations) abrogates recognition. Thus, antigen specificity emerges
because TCR residues that contact the peptide are enriched in amino acids that
interact weakly with other amino acids. It is worth remarking that weakly binding
amino acids are not always the mediators of recognition; TCR selected against one
type of peptide do not exhibit this behavior (Huseby et al., 2005, 2006).
Because the amino acids treated explicitly in our model include variable MHC
residues, our results are also consistent with data showing that TCR selected against
many peptides are also MHC specific. We note in passing that we have also studied
the alloreactivity of selected TCRs, i.e. reactions against nonself MHC molecules
(data not shown). Our findings suggest that the relative importance of the peptide
(compared with the MHC) in mediating alloreactive responses depends on how dif-
ferent the allo- and endogenous MHCs are vis-h-vis their interaction energies with
the CDR1 and CDR2 loops of a particular TCR (Ec in our model); the greater this
difference, the less important the peptide.
Our results suggest a model for specificity of TCR-antigenic pMHC recognition
that is different from Fisher's lock and key metaphor for the specificity with which an
enzyme binds its substrate (Fischer, 1894). It also appears to be different from that
applicable to specificity of antibody-antigen interactions where shape complemen-
tarity and multiple weak interactions are inextricably coupled (Perelson and Oster,
1979). Shape complementarity is important for TCR recognition of antigen in two
ways (Figure 2-10). First, it plays a key role in peptide binding to the MHC groove,
and hence influences antigen presentation. Secondly, shape complementarity is possi-
bly important in mediating interactions of the TCR with MHC moieties, which results
in orienting the TCR in a way that juxtaposes its peptide contact residues with the
peptide. Indeed, it has been suggested that if the peptide has a conformation that
is not relatively flat, it disrupts TCR-MHC interactions, thereby preventing posi-
tive selection (Schumacher and Ploegh, 1994). But, these TCR-MHC interactions
required for positive selection and binding of peripheral TCRs to MHC in the proper
orientation do not confer peptide specificity.
Once properly oriented, a TCR scans the relatively flat conformation of the short
peptide, and recognizes the epitope if a number of peptide amino acids correspond
to strong binders for the weak peptide contact residues of this TCR. For reasons de-
scribed above, recognition is specific because each resulting interaction is moderate.
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Figure 2-10: A bar code scanning model for specificity of TCR recognition of antigenic
peptides. The thickness of the lines in the cartoon is proportional to the strength of
TCR-peptide interactions. This figure is adapted from Figure 4 in (Kosmrlj et al.,
2008).
Shape complementarity seems to be decoupled from the origin of specificity. TCR,
recognition of antigen is analogous to scanning a flat bar code for the appropriate
number of moderately thick lines. In this metaphor, the moderately thick lines repre-
sent moderate interactions mediated by peptide amino acids that are strong binders
for the weak amino acids that comprise the TCR's peptide contact residues. This
bar-code model also makes vivid why specificity and cross-reactivity can coexist. For
example, consider a situation where any three of four contacts with the peptide amino
acids need to be of moderate scale for recognition; i.e., three of the four lines need
to be moderately thick. If a particular peptide satisfies this criterion (say, lines 1,
3, and 4 are moderately thick), mutations at any one of these sites will abrogate
recognition (specificity). But another peptide that leads to lines 1, 2, and 3 being
moderately thick will also be recognized by this TCR (cross-reactivity). One might
say that TCRs scan a bar code and recognize statistical patterns - ones that have a
sufficient number of moderately thick lines.
We hope that the results we have reported will motivate experimental and compu-
tational studies that will ultimately elucidate how one of nature's intriguing designers
(the thymus) works and how its aberrant regulation can contribute to autoimmune
disease. An important question unresolved by our studies is how variability in ex-
pression levels of different types of endogenous peptides in the thymus influences the
T cell repertoire.
Chapter 3
Thymic selection of T-cell
receptors as an extreme value
problem
The adaptive immune system clears pathogens from infected hosts with the aid of T
lymphocytes (T cells). Foreign (antigenic) and self-proteins are processed into short
peptides (p) inside antigen-presenting cells (APC), bound to MHC proteins, and pre-
sented on the surface of APCs. Each T-cell receptor (TCR) has a conserved region
participating in the signaling functions, and a highly variable segment responsible for
antigen recognition. Because variable regions are generated by stochastic rearrange-
ment of the relevant genes, most T cells express a distinct TCR. The diversity of the
T cell repertoire enables the immune system to recognize many different antigenic
short pMHC complexes. Peptides presented on MHC class I are typically 8-11 amino
acids long (Kuby et al., 2006), which is enough to cover all possible self-peptides
(the human proteome consists of P ~ 107 amino-acids (Burroughs et al., 2004; Flicek
et al., 2008)) as well as many antigenic peptides. TCR recognition of pMHC is both
specific and degenerate (Figure 1-2). It is specific, because most mutations to the
recognized peptide amino acids abrogate recognition (Huseby et al., 2006, 2005). It
is degenerate because a given TCR can recognize several antigenic peptides (Hemmer
Part of this chapter is based on the publication (Kosmrlj et al., 2009).
et al., 1998; Kersh and Allen, 1996; Misko et al., 1999; Sloan-Lancaster and Allen,
1996; Unanue, 1984).
The gene rearrangement process ensuring the diversity of TCR is random. It may
thus result in T cells potentially harmful to the host, because they bind strongly to
self peptide-MHC complexes; or useless T cells which bind too weakly to MHC to
recognize antigenic peptides. Such aberrant TCRs are eliminated in the thymus (von
Boehmer et al., 2003; Werlen et al., 2003; Siggs et al., 2006; Hogquist et al., 2005),
where immature T cells (thymocytes) are exposed to a large set (103 - 104) of self-
pMHC (see also subsection 1.1.3 and Figure 1-3). Thymocytes expressing a TCR
that binds with high affinity to any self-pMHC molecule are deleted in the thymus
(a process called negative selection). However, a thymocyte's TCR must also bind
sufficiently strongly to at least one self pMHC complex to receive survival signals and
emerge from the thymus (a process called positive selection).
3.1 Thymic selection model
Signaling events, gene transcription programs, and cell migration during T cell devel-
opment in the thymus (von Boehmer et al., 2003; Werlen et al., 2003; Siggs et al.,
2006; Hogquist et al., 2005; Daniels et al., 2006; Bousso et al., 2002; Borghans et al.,
2003; Scherer et al., 2004; Detours et al., 1999; Detours and Perelson, 1999) have
been studied extensively. Despite many important advances, how interactions with
self-pMHC complexes in the thymus shape the peptide-binding properties of selected
TCR amino acid sequences, such that mature T cells exhibit their special properties,
is poorly understood. To address this issue, in Chapter 2 and reference (Kosmrlj
et al., 2008) we numerically studied a simple model where TCRs and pMHC were
represented by strings of amino acids (Figure 2-1). These strings indicate the amino-
acids on the interface between TCRs and pMHC complexes, and it is assumed that
each site on a TCR interacts only with a corresponding site on pMHC. The binding
interface of TCR is actually composed of a region that is in contact with the MHC
molecule, and a segment that is in contact with the peptide. It is the latter part that
is highly variable, while the former is more conserved. We shall therefore explicitly
consider only the former amino-acids, but not the latter. Similarly, there are many
possible peptides that can bind to MHC, and their sequences are considered explicitly,
whereas those of the MHC are not. We could in principal add a few sites to the TCR
and pMHC strings to account for any variability in the segments not considered.
Simplified representations of amino-acids (e.g., as a string of numbers or bits)
were employed earlier (Detours et al., 1999; Detours and Perelson, 1999; Chao et al.,
2005) in the context of TCR-pMHC interactions, mainly to report that negative se-
lection reduces TCR cross-reactivity. In Chapter 2 and reference (Kosmrlj et al.,
2008), we numerically studied the model in Figure 2-1 (and described below) to
qualitatively describe the role of positive and negative selection on the amino-acid
composition of selected TCRs. By randomly generating TCR and pMHC sequences,
and implementing thymic selection in silico, we showed that selected TCRs are en-
riched in weakly interacting amino acids, and explained how this leads to specific,
yet cross-reactive, TCR recognition of antigen, a long-standing puzzle (see Chapter 2
and reference (Kosmrlj et al., 2008)). In this Chaper we show that the model can
be solved exactly in the limit of long TCR/peptide sequences. The resulting analytic
expression for the amino-acid composition of selected TCRs is surprisingly accurate
even for short peptides and provides a theoretical basis for previous numerical results.
Furthermore, we are able to obtain a phase diagram that indicates the ranges of pa-
rameters where negative or positive selection are dominant, leading to quite different
bias in selection/function.
To assess the effects of thymic selection, as well as antigen recognition, we evaluate
the free energy of interaction between TCR-pMHC pairs (for brevity, free energy will
be referred to as energy). The interaction energy is composed of two parts: a TCR
interaction with MHC, and a TCR interaction with the peptide. The former is given
a value Ec (which may be varied to describe different TCRs and MHCs). The latter
is obtained by aligning the TCR and pMHC amino-acids that are treated explicitly,
and adding the pairwise interactions between corresponding pairs. For a given TCR-
pMHC pair, this gives
N
Eint (i s) = Ec + 3 J(ti, si), (3.1)
i=1
where J(ti, si) is the contribution from the ith amino acids of the TCR (ti) and
the peptide (si), and N is the length of the variable TCR/peptide region. The
matrix J encodes the interaction energies between specific pairs of amino-acids. For
numerical implementations we use the Miyazawa-Jernigan (MJ) matrix (Miyazawa
and Jernigan, 1996) that was developed in the context of protein folding.
Immature T cells interact with a set S of M self-pMHC complexes, where typically
M is of the order of 103 - 104 . To mimic thymic selection, sequences that bind to
any self-pMHC too strongly (Eint < E,) are deleted (negative selection). However, a
thymocyte's TCR must also bind sufficiently strongly (Eint < Ep) to at least one self-
pMHC to receive survival signals and emerge from the thymus (positive selection).
A thymocyte expressing TCR with string t will thus be selected if the strongest
interaction with self-pMHC is between thresholds for negative and positive selection,
i.e.
E, < min{Eint (tf l) } < Ep. (3.2)
Recent experiments (Daniels et al., 2006) show that the difference between thresholds
for positive and negative selection is relatively small (a few kBT).
3.1.1 Extreme value problem
Equation (3.2) casts thymic selection as an extreme value problem (Leadbetter et al.,
1983), enabling us to calculate the probability Psei(t) that a TCR sequence t will
be selected in the thymus. Let us indicate by p(xlF) the probability density function
(PDF) of the interaction energy between the TCR tand a random peptide. The PDF
(x lr) of the strongest (minimum) of the M independent random interaction energies
is then obtained by multiplying p with the probability of all remaining (M -1) energy
values being larger - (1 - P(E < xl)) , where P(E < xt) is the cumulative
probability - and noting the multiplicity M for which energy is the lowest. The
probability that TCR f is selected is then obtained by integrating fJ(xit) over the
allowed range, as
Ep
Psei(t) jll (f) d, with
E
H (xF) M p(l) (1 - P(E < l)) (3.3)
For M > 1, this extreme value distribution (EVD) converges to one of three possible
forms, (Leadbetter et al., 1983) depending on the tail of the PDF for each entry.
Equation (3.1) indicates that in our case as each energy is the sum of N contributions,
p(x i) should be a Gaussian for large N, in which case the relevant EVD is the Gumbel
distribution. (Leadbetter et al., 1983)
To obtain an explicit form for ll(rlF), we model the set S of self-peptides as M
strings in which each amino-acid is chosen independently. The probability f, for
selecting amino-acid a at each site is taken to be the frequency of this amino-acid
in the self-proteome. For a specific TCR sequence t, the average interaction energy
with self peptides follows from Equation (3.1) as Eav(f) = Ec + EN I e(ti), with
E(t ) = [J(ti, a)],, where we have denoted the average over self amino-acid frequencies
by [G(a)]a faG(a). Similarly, the variance of the interaction energy is V(r) =
NI V(ti), where V(ti) = [J(ti, a)2 ]a - [J(ti, a)] . For large N, we can approximate
p(xlf) with a Gaussian PDF with the above mean and variance. From standard
results for the Gumbel distribution (Leadbetter et al., 1983), we conclude that in the
limit of M > 1, the peak of the distribution H(xK) is located at
Eo (tF) = Eav (t) - 2V () In M, (3.4)
and its width is Eo(t) = W72V()/(121n M). (Since the PDF p(x f) originates from
a bounded set of energies, it is strictly not Gaussian in the tails. Hence, once the
extreme values begin to probe the tail of the distribution, the above results will no
longer be valid. Indeed, in the limit when M ~ 0(20N), the EVD will approach
a delta-function centered at the M-independent value corresponding to the optimal
binding energy.)
3.1.2 Hamiltonian minimization
In the limit of long TCR/peptides (N > 1), we can exactly calculate the statistics
of the amino-acid composition of selected TCRs. To obtain a proper thermodynamic
limit, we need to set {Ec, E,, E,} oc N, and ln M oc N. The latter ensures that
the peak of the distribution, Eo(f), is proportional to N, and also results in a width
Eo(F) which is independent of N. (The relation ln M = aN can be justified with
the expectation that M should grow proportionately to the proteome size P, while
N c< In P to enable encoding the proteome.) In this large N limit, the EVD is
sufficiently narrow that the value of the optimal energy can be precisely equated with
the peak Eo(F), and Equation (3.2) for the selection condition can be replaced with
N N
En < Ec + Z (ti) - 2 In M V(ti) < E,. (3.5)
i=1i=
Thus, for each sequence t we have to evaluate the 'Hamiltonian' Eo(t), and the
sequence is accepted if this energy falls in the interval (En, E,). This is somewhat
similar to the micro-canonical ensemble in Statistical Physics, with the restriction of
the energy to an interval rather than a narrow range only a minor elaboration (see
below). From the equivalence of canonical and micro-canonical ensembles for large
N, we know that the probability for a sequence is governed by the Boltzmann weight
P() c ( 1 f exp[-3Eo()]. Here {ff} indicate the natural frequencies of the
different amino-acids prior to selection, while the effect of thymic selection is captured
in the parameter /3 which is determined by solving for the average energy.
The presence of 2 ln M V(ti) in the Hamiltonian initially appears as a com-
plication that makes exact computation of the average energy from exp[-3Eo()]
impossible. However, this apparent 'coupling' is easily dealt with by standard meth-
ods such as Legendre transforms or Hamiltonian minimization (Kardar, 1983). This
can be justified easily as follows: We need to solve a 'Hamiltonian' 'H(l1, V) which
a #>0 b #= 0 c #<0
E,, Ep = (Eo) E, EP (Eo) = E,, E,
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Figure 3-1: Schematic presentation of the choice of parameter 0 that constraints the
average energy (Eo) to the range in Equation (3.5), while maximizing entropy. Three
cases above correspond to the examples where (a) /3 > 0, (b) 3 = 0 and (c) 3 < 0.
depends on two extensive quantities U = Eb 1  (ti) and V Nt1 V(ti). The corre-
sponding partition function can be decomposed as Z = E v (U, V)e-jH(U,V) but
can be approximated with its largest term. Note that the same density of states
Q(U, V) -- eS(U,V)/kB appears, irrespective of the specific form of 7(U, V). In particu-
lar, the choice NO = E+U -- yV -In M/(2-y) = Ec+ EN [(E(ti) -yV(ti)] -In M/(2-y)
corresponds to a set of non-interacting variables, with
N
p(f) oc 1 ft, exp - 3(E(ti) - -yV(ti))], (3.6)
for which thermodynamic quantities (such as entropy) are easily computed. By ju-
dicious choice of -y we can then ensure that the same average energy appears for
No(t) and our Eo(F). Using Legendre transforms, which is equivalent to minimiz-
ing No(t) with respect to -y, one finds that the required Eo(T) is obtained by set-
ting -y(/3) In M/(2N (V),,), where (- ) refers to the average with the non-
interacting weight e-O(U-V).
Finally, the value of 3 has to be determined by constraining the average energy
determined above to the range in Equation (3.5), while maximizing entropy (Figure 3-
1). Given the bounded set of energies, the inverse temperature 3 can be either
negative or positive. The 2 0 N possible values for Eo(F) span a range from Emin to
Emax, and a corresponding number of states Q(Eo) which is a bell-shape between
32.5
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Figure 3-2: Color representation of the dependence of the inverse temperature # on
the number of self-peptides in M/N and the threshold for negative selection energy
En/N with (E, - En)/N = 0.5kBT in the limit of large N. The region between
the black lines corresponds to / = 0, to the right (left) of which negative (positive)
selection is dominant, and weak (strong) amino-acids are selected. Note that as
(Ep - E,)/N goes to zero, the intermediate region disappears. The dotted lines
indicate the relevant parameter values for thymic selection in mouse (see text) that
result in / = -0.37(kBT)-'. This figure is adapted from Figure 2 in (Kosmrlj et al.,
2009).
these extremes with a maximum at some Emid. If Emid > E,, we must set / such
that (Eo()) = E,. In this case, # > 0, positive selection is dominant and stronger
amino-acids are selected. If Emid < En, we must set / such that (Eo(E)) = En,
/3 < 0, negative selection is dominant and weaker amino-acids are selected. For
En < Emid < E,, we must set / = 0 and there is no modification due to selection.
Figure 3-2 depicts the variation of / as a function of ln(M)/N and threshold for
negative selection En with (Ep - En)/N = 0.5kBT. For the set of parameters that
are relevant for thymic selection in mouse (Chapter 2 and (Kosmrlj et al., 2008)),
i.e. N = 5, En - Ec = -21kBT, E, - En = 2.5kBT and M = 103, we find # =









acids are selected. Also -y = 0.83(kBT)-' indicating a preference for amino-acids with
smaller variations in binding energy. With these parameters we can calculate the
amino-acid frequencies of selected TCRs as
f(sel) - faexp [ - /3(8(a) - 7yV(a))]
" Zi 1 fhexp [- 3(E(b) - -yV(b))]
It is important to ask if the above expression, exact in the limit of N -+ oc, has
any relevance to the actual TCR/peptides with N ~ 5 - 10. We thus numerically
simulated the case of N = 5 by generating a random set of 106 TCR sequences,
and selected them against M = 103 self-peptides. The selected TCRs were used to
construct the amino-acid frequencies depicted in Figure 3-3. The red line in this
figure comes from Equation (3.7) with the same J and {fa}. The agreement between
the two is remarkable given the small value of N = 5, and may be indicative of
small corrections to the N -- oc result. Since 3 < 0 for the relevant parameters,
the positive selection has no effect in the limit of N -- oc. To test the effect of
positive selection in simulations, we have repeated the simulations of thymic selection
with only the negative selection process (i.e. every TCR is positively selected or
(Ep - En)/N -* -0c). Amino acid frequencies of thus selected TCRs are presented
with green data points on Figure 3-3 and they are similar to TCRs (black data points),
which were selected with both the negative and positive selection processes. The one
effect we notice, is that the removal of positive selection (green data points) makes
the errorbars smaller and thus the analytical result, becomes less accurate (- 50%)
for strongly interacting amino acids (e.g. L). The reason for large discrepancy is likely
due to the differences between the micro-canonical and canonical ensembles, which
should be more pronounced for small values of N.
3.2 T cell recognition of foreign peptides
Once T cells complete the thymic selection, a set T of TCRs (K in number) is
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Figure 3-3: Amino-acid composition of selected TCR sequences, ordered in increasing
frequency along the abscissa. The data points in black are obtained numerically with
the parameters relevant to mouse (see caption of Figure 3-2, and text). The error bars
reflect the sample size used to generate the histograms and differences for different
realizations of M self-peptides. The red line is the result of the EVD analysis in
the large N limit from Equation (3.7), and the agreement is quite good. The data
points in green are obtained numerically with the parameters relevant to mouse,
where the effect of positive selection was ignored ((Ep - E,)/N -+ -oo, i.e. every
TCR is positively selected). In all cases we have used the Miyazawa-Jernigan matrix
J (Miyazawa and Jernigan, 1996), and amino acid frequencies fa from the mouse
proteome (Table 2.1 and (Flicek et al., 2008; Kosmrlj et al., 2008)). This figure is
adapted from Figure 3 in (Kosmrlj et al., 2009).
recognizes infected cells when its TCR binds sufficiently strongly (Eint < E,) to
foreign peptide-MHC. Experimental evidence (Naeher et al., 2007) suggests that the
negative selection threshold in the thymus is the same as the recognition threshold
in the periphery, i.e. E, = E,. This means that a foreign peptide of sequence S is
recognized if its strongest interaction with the set of TCRs exceeds the threshold for
recognition, i.e.
min{ Eint (t S)}I < E,. (3.8)
t6ET
Equation (3.8) casts the recognition of foreign peptides as another extreme value
problem. From the previous section we already know how to calculate the probability
Pre (S) that a foreign peptide sequence g is recognized by T cells and how to calculate
the amino acid composition of recognized foreign peptides in the limit of long peptide
sequences. Therefore, here we just briefly summarize the necessary steps.
Let us indicate by p* (xls) the PDF of the interaction energy between the foreign
peptide S and a random TCR that is selected in the thymus. Then the probability
that foreign peptide s is recognized is obtained by integrating the extreme value
distribution H* (xls) over the allowed range, as
Prec (S) = / I *l*(x s) dx, with
-oo1
fl*(xzs) = K p*(xzs) (1 - P*(E < 3s9))K1)
(Note that compared to Equation (3.3), there is no lower bound to the interaction
strength.) If we model the set T of selected T cells as K strings in which each amino
acid is chosen independently with frequencies f,,"l) (i.e. we ignore the correlations
among different positions on the string), then in the limit of long peptide sequences
(large N) we can approximate the PDF p* (xzs) with a Gaussian with the mean
Ea*v () = Ec + EN E*(si) and the variance V*(s) => 1 V*(si). The mean E*(si)
and the variance V*(si) of the amino acid interaction energies are obtained as in the
previous section by appropriately replacing {fa} with {f *1 }. In the limit of large
number of T cells (K > 1) the extreme value distribution fl* (xs) is sharply peaked
around
E*(S-) = Ea() -- 2V*(9) ln K, (3.10)
and in the large N limit the condition for recognition of foreign peptides becomes
E* (S') < En . (3.11)
The probability for a sequence s to be recognized is governed by the Boltzmann
weight p(N) ( i exp[- 7*E3(s)], where {fa} are natural frequencies of dif-
ferent amino acids in the pathogen proteome, while the effect of TCR recognition is
captured in the parameter 0*. As in the previous section, we introduce a new Hamil-
a /*[(kBT)-l] B *[(kT)-]
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Figure 3-4: Color representation of the dependence of the parameter 0* on the number
of selected TCRs (ln(K)/N), the number of self peptides (ln(M)/N) against which
TCRs were selected, and threshold for negative selection E,/N with (Ep - E,)/N =
0.5kBT, in the limit of large N. Solid black lines separate regions with 0* > 0 and
/3* - 0. The region between the black dashed lines corresponds to / 0 (every TCR
is selected). (a) (E, - Ec)/N = -4.2kBT; (b) ln(K)/N = 1.5.
tonian H-(s) - Ec + EI [E*(si) - _y*V*(si)] - ln K/(2-y*), and to ensure the same
average energies (E (s)) and (N1 (s)) we set -*(0*) - lnK/ (2N(V*).,-). Finally,
the value of 0* is determined by constraining the average energy (Eg(s)) < E,, while
maximizing entropy. If Emi > E,,, we must set /3* such that (Eo (S)) = E,, where
Emid is defined like in the previous section. In this case, 3* > 0, and only foreign
peptides with stronger amino acids are recognized. If Emid < En, we must set 0* = 0,
and there is no modification due to recognition, i.e. every foreign peptide is recog-
nized. Note that unlike for the thymic selection of T cell receptors (the parameter
/), the parameter 3* cannot be negative, because there is no lower energy bound for
recognition in Equation (3.11). With all parameters determined, we can calculate the
amino acid frequencies of recognized foreign peptides
rec) ___fa exp [ -/*(E*(a) - y*V*(a))] (3.12)
"c Zl fb exp [ - 3*(E*(b) - y*V*(b))]
Figure 3-4 depicts variation of /* as a function of the number of selected TCRs
(ln(K)/N), the number of self peptides (ln(M)/N) against which TCRs were selected,
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Figure 3-5: Amino-acid composition of recognized foreign peptides, ordered in de-
creasing frequency along the abscissa. The data points in black are obtained nu-
merically with the parameters relevant to the TCR selection in mouse and K = 103
TCRs where than challenged with Listeria monocytogenes peptides (see text). The
error bars reflect the sample size used to generate the histograms and differences for
different realizations of M self-peptides. The red line is the result of the EVD anal-
ysis in the large N limit from Equation (3.12), where TCR amino acid frequencies
were obtained from Equation (3.7). The dashed lines correspond to the result of the
EVD analysis in the large N limit, where the selected TCR amino acid frequencies
were taken from simulation results (dashed blue line) or where the effective number
Keff 0.67 x 103 of TCRs is used to take into account the correlations of selected
TCR sequences (dashed green line). In all cases we have used the Miyazawa-Jernigan
matrix J (Miyazawa and Jernigan, 1996), amino acid frequencies fa from the mouse
proteome and amino acid frequencies fa from the Listeria monocytogenes proteome
(Table 2.1 and (Flicek et al., 2008; Kosmrlj et al., 2008)).
and the threshold for negative selection En/N with (Ep - En)/N = 0.5kBT. The
region 0* = 0 is possible only for K > M and for parameters where 101 is small
(cf. Figure 3-2). Finally we compared the analytical results, which are exact in the
limit N -+ oc with numerical simulations for N = 5 (Figure 3-5). From the set of
parameters that are relevant for thymic selection in mouse (i.e. N = 5, E, - En =
2.5kBT, En - Ec = -21kBT and M = 103), we generated a pool of K = 103 selected
TCRs. Then we randomly generated 106 foreign peptides with amino acid frequencies
fa, which were representative of Listeria monocytogenes (Table 2.1), and checked the
amino acid composition of foreign peptides that were recognized by at least one TCR.
We find that selected TCRs recognize only foreign peptides that are enriched with
strongly interacting amino acids (Figure 3-5). The agreement between simulations
(black line) and analytical result (red line, 3* = 0.11(kBT) 1 and 7}* = 0.96(kBT)-)
is not very good (Figure 3-5). One source of discrepancy could be due to differences
in amino acid composition of selected TCRs f,,e1) (cf. Figure 3-3). Using f*sel)
obtained from simulations as an input for analytical result (dashed blue line, 0* =
0.26(kBT)' and -7 1.06(kBT) 1) makes only slight improvement. This suggests
that our assumption that the pool T of selected TCRs is uncorrelated, might not
be good for short sequences. To test the effect of correlations, we generated a set
of K = 0 uncorrelated TCRs with amino acid frequencies fase1) obtained from
Equation (3.7) and then checked the amino acid composition of foreign peptides
recognized by this set. Figure 3-6 shows better agreement between the analytical
result (red line) and simulations (blue data points) with uncorrelated TCRs. However,
the analytical result is still off for up to 40% and the large discrepancy is likely due
to the inaccurate approximation of micro-canonical with the canonical ensemble of
recognized foreign peptides for short peptides (N = 5). Worse agreement between
the numerical and analytical results for the amino acid composition of recognized
peptides (Figure 3-6) compared to the results for the amino acid composition of
selected TCRs (Figure 3-3) might be due to lower magnitude of numerically obtained
parameters |#*1 = 0.11kBT' < 13 0.37kBT-' and the exponential dependence of
amino acid frequencies on parameters / and /* (Equations (3.7) and (3.12)).
To quantify the degree of correlations, we calculated the "effective" TCR repertoire
size from the Shannon entropy (Shannon, 1948)
SN p npr, (3.13)
{2'}
where pr is the (joint) probability for the TCR sequence iF to appear in the selected
TCR repertoire. It is given by pr = C [HJN ft x Psei(ti), where the product of
ft, factors corresponds to the probability that the TCR sequence t is generated, the
I I I I I I I I I I I I I I I I I
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Figure 3-6: Amino-acid composition of foreign peptides recognized by uncorrelated
TCRs, ordered in decreasing frequency along the abscissa. The data points in blue
are obtained numerically where a set of K = 103 uncorrelated TCRs is challenged
with Listeria monocytogenes peptides (see text). The error bars reflect the sample
size used to generate the histograms and differences for different realizations of K
uncorrelated TCRs. The red line is the result of the EVD analysis in the large
N limit from Equation (3.12), where TCR amino acid frequencies were obtained
from Equation (3.7). In both cases we have used the Miyazawa-Jernigan matrix
J (Miyazawa and Jernigan, 1996), amino acid frequencies fsel from Equation (3.7)
and amino acid frequencies fa from the Listeria monocytogenes proteome (Table 2.1
and (Flicek et al., 2008; Kosmrlj et al., 2008)).
Psei(f) corresponds to the probability that the TCR sequence t is selected in the
thymus, and C is the normalization constant. For the model parameters relevant
to mouse (N - 5, En - Ec = -21kBT, E, - En - 2.5kBT and M = 103), we
numerically estimated the probabilities Psei(7) for each of the 20 N sequences ' by
calculating the average probability that a given sequence t is selected against M =
103 self peptides averaged over 1,000 different realizations of M self peptides. Thus
we obtained numerically the "effective" TCR repertoire size exp(SN) ~ 0.64 x 106.
Assuming that the selected TCR sequences are uncorrelated, the "effective" TCR
repertoire size can be calculated also from the amino acid frequencies f(1") of selected
TCRs. In this case the Shannon entropy is
20
Si = f(sel) In fjsel). (3.14)
a=1
For the amino acid frequencies flse) obtained from numerical simulations, the size of
the "effective" TCR repertoire is exp(NSI) ~ 0.96 x 106. The size of the "effective"
TCR repertoire obtained for analytically determined amino acid frequencies f sel)
from Equation (3.7) is exp(NSI) ~ 1.08 x 106. The correlations thus reduce the
"effective" TCR repertoire size by approximately one third. In analytical results
(Equation (3.12)) the effect of correlations can be approximated by using an effective
number of TCRs Keif exp(S) K. Using Kef 0.67 x 103 leads to parameters
/* 0.14(kBT) 1 and 7 0.93(kBT), resulting only in a very slight change of
amino acid frequencies of recognized peptides (dashed green line in Figure 3-5) and
they are still far from the results of simulations (black data points). This suggests
that the effect of correlations is much larger for short sequences (N = 5) and for the
chosen parameters.
It is important to note that a mouse has ~ 10' distinct T cells and a human has
10 distinct T cells. Both numbers are larger than the size of the "effective" TCR
repertoire (~ 106), as well as the total number of possible sequences 2 0 N for N = 5.
This suggests that the sequence length N should be larger (N = 6 or N = 7) or
that TCRs differ also in regions that do not bind peptide, e.g. there are different
sets of TCR pools that correspond to different MHC types (each human has up to
12 different MHC types). For the values of K that are of the order of the "effective"
repertoire size or larger, the EVD I* probes the tails of distribution p* (xjs), where
it is no longer Gaussian. Because the distribution p* (xvs) is bounded, in the large
K limit the EVD approaches a delta-function centered at the K-independent value
corresponding to the optimal binding energy:
N
EO*(S) = Ec + min J(tj, si). (3.15)
f ET}1
In the limit N - oc, a pool of TCR sequences is uncorrelated and the optimal binding
energy can be written as:
N
EO* Ec + Jmin(Si), (3.16)
i=1
where Jmin (a) = minb J(b, a). The condition for recognition of foreign peptides is
EO*(S) < En, (3.17)
and the probability for a sequence s to be recognized is governed by the Boltzmann
weight p(s) c (H exp[-#3*E3(s)], where {fa} are natural frequencies of dif-
ferent amino acids in the pathogen proteome, while the effect of TCR recognition
is captured in the parameter #*. The value of 0* is determined by constraining the
average energy (Eg(s)) < En, while maximizing entropy in the same manner as de-
scribed before (see the paragraph after Equation (3.11)). The condition for 0* > 0
can be simplified to:
En- Ec 20 Jmin(a) fa exp [ - J (a)]
= (Jmin(a)) = 20 (318)
N E _= 1 fa exp [ - /*Jmin(a)]
With the parameter 3* determined, we can calculate the amino acid frequencies of
recognized foreign peptides
j(rec) 
_ fa exp *- Jmin(a)] (3.19)
"a ~24_ fb exp [ - #*Jmin(b)]
For the relevant parameters in mouse (i.e. N = 5, EP - E, = 2.5kBT, En- Ec
-21kBT and M 310), we obtain 3* = 0, which means that every peptide is rec-
ognized. We tested this numerically by generating all 20N possible TCR sequences
t with appropriate weights (jJjH ft,), which are then selected in the thymus against
M = 103 self peptides and then challenged against 10' randomly generated foreign
peptides that were representative of Listeria monocytogenes. Figure 3-7 shows a large
disagreement between numerical simulations (black data points) and this analytical
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Figure 3-7: Amino-acid composition of foreign peptides recognized by a complete
pool of selected TCRs, ordered in decreasing frequency along the abscissa. The data
points in black are obtained numerically where a complete pool of selected TCRs
(obtained from thymic selection of all all 2 0 N TCR sequences against M = 103 self
peptides) is challenged with L. monocytogenes peptides (see text). The error bars
reflect the differences for different realizations of M - 103 self peptides. The red line
is the result of the EVD analysis in the large N limit from Equation (3.19). The
data points in blue are obtained numerically where a complete pool of uncorrelated
TCRs, which is equal to the complete pool of 2 0 N sequences (see text), is challenged
with L. monocytogenes peptides. In this case, there are no errorbars, because we use
the complete pools of TCRs and foreign peptides with appropriate weights. In all
cases we have used the Miyazawa-Jernigan matrix J (Miyazawa and Jernigan, 1996),
amino acid frequencies fa from human and amino acid frequencies fa from the L.
monocytogenes proteome (Table 2.1 and (Flicek et al., 2008; Kosmrlj et al., 2008)).
result (red line). Because the selected TCRs are correlated, we also tested the effect of
correlations. Since f,,e1) > 0 for every amino acid a, the complete pool of uncorrelated
TCRs correspond to all 2 0 N sequences with weights (]~ f sel)). When a foreign pep-
tide is tested against the complete pool of TCRs, it finds a TCR that results in optimal
binding energy (Equation 3.16). To numerically calculate the amino acid frequencies
of foreign proteins recognized by complete uncorrelated pool of TCRs, we generate all
possible 2 0 N foreign peptide sequences with appropriate weights (]l N fj,). A foreign
peptide sequence s is then recognized if the optimal binding energy (Equation 3.16)
exceeds the recognition threshold (Equation 3.17). The numerical result for uncor-
related TCRs (blue data points) agrees very well with the analytical results, which
indicates that the correlations in selected TCR sequences have an important role.
3.3 Conclusions
Equation (3.7) provides an analytical expression that captures the characteristics of
TCR amino-acids selected against many peptides in the thymus. In accord with pre-
vious numerical results presented in Chapter 2 and reference (Kosmrlj et al., 2008),
and some available data from normal mouse and human, it predicts (since 0 < 0)
that TCR sequences are enriched in weakly interacting amino-acids (small E). This
result was used previously (Kosmrlj et al., 2008) to explain their specificity. However,
Equation (3.7) further indicates the role of promiscuity of amino-acids (captured by
the parameter -y) which was not elucidated from the limited numerical data. Further-
more, the phase diagram in Figure 3-2 indicates how upon raising the number of self-
peptides there is a transition from preference for strong amino-acids (0 > 0, positive
selection dominant) to weak amino-acids (0 < 0, negative selection dominant), which
may be feasibly tested in future experiments, along the lines in reference (Huseby
et al., 2006).
Equations (3.12) and (3.19) provide an analytical expression that captures the
characteristics of amino-acids of the recognized foreign peptides. Figures 3-5 and 3-
7 show that the analytical result is not very accurate for short (N = 5) peptide
sequences and we showed (Figures 3-6 and 3-7) that this is due to the correlations in
selected TCR sequences. In the future it would be interesting to study how (or if)
these correlations vanish as peptide sequence length (N) is increased.
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Chapter 4
Effects of thymic selection of the
T-cell repertoire on HLA class
I-associated control of HIV
infection
Without therapy, most people infected with human immunodeficiency virus (HIV) ul-
timately progress to AIDS. Rare individuals (elite controllers) maintain very low levels
of HIV RNA without therapy, thereby making disease progression and transmission
unlikely. Certain HLA class I alleles (human MHC is called HLA) are markedly en-
riched in elite controllers, with the highest association observed for HLA-B57 (Migue-
les et al., 2000). Because HLA molecules present viral peptides that activate CD8+
T cells, an immune-mediated mechanism is probably responsible for superior con-
trol of HIV. In this Chapter, we describe how the peptide-binding characteristics of
HLA-B57 molecules affect thymic development such that, compared to other HLA-
restricted T cells, a larger fraction of the naive repertoire of B57-restricted clones
recognizes a viral epitope, and these T cells are more cross-reactive to mutants of tar-
geted epitopes. Our calculations predict that such a T-cell repertoire imposes strong
This chapter is based on the publication (Kosmrlj et al., 2010).
immune pressure on immunodominant HIV epitopes and emergent mutants, thereby
promoting efficient control of the virus. Supporting these predictions, in a large cohort
of HLA-typed individuals, our experiments show that the relative ability of HLA-B
alleles to control HIV correlates with their peptide-binding characteristics that affect
thymic development. Our results provide a conceptual framework that unifies diverse
empirical observations, and have implications for vaccination strategies.
HIV infection leads to acute high level viraemia (the measurable presence of virus
in the bloodstream), which is subsequently reduced to a set-point viral load. Without
therapy, most patients experience a subsequent increase in viral load, and ultimately
the development of AIDS. Viraemia levels and time to disease vary widely, and the
differences correlate with the expression of different HLA class I molecules (reviewed
in reference (Deeks and Walker, 2007)). Effector CD8+ T cells (CTLs) are implicated
in viral control because T-cell antigen receptors (TCRs) on CD8+ T cells recognize
complexes of viral peptides and class I HLA molecules presented on the surface of
infected cells, and depletion of CD8+ T cells leads to increased viraemia in animal
models of HIV infection (Jin et al., 1999). We describe a feature of the HLA-B57-
restricted CD8+ T-cell repertoire that contributes to enhanced control of viraemia.
4.1 HLA-B57 binds fewer types of self peptides
Algorithms (Peters et al., 2005) based on experimental data predict whether a par-
ticular peptide will bind to a given HLA molecule (Rao et al., 2009). We tested
four predictive algorithms against available experimental data on peptide binding
to diverse HLA molecules and found that, in most cases, they are highly accurate
(Figure B-1 and Table B.1). For example, predictions using the best algorithm for
HLA-B*5701 were 97% accurate. Using these algorithms, we computed the fraction
of peptides derived from the human proteome (Hubbard et al., 2009) that bind to
various HLA molecules. Of the - 107 unique peptide sequences, only 70,000 are pre-
dicted to bind to HLA-B*5701, and 180,000 bind to HLA-B*0701 (an allele that is
not protective against HIV). Essentially identical results were obtained for randomly
generated peptides (data not shown). The protective allele in macaques, Mamu-
B*17, also binds fewer self peptides than other Mamu molecules for which data are
available (Mamu-B*17 binds 4, 6 and 13 times fewer self peptides than Mamu-A*11,
Mamu-A*01 and Mamu-A*02, respectively; Table B.1).
The intrinsic differences in self-peptide binding among HLA molecules are impor-
tant during T-cell repertoire development. Immature T cells are exposed to diverse
host-derived peptide-HLA complexes presented in the thymus. As fewer self peptides
are able to bind to HLA-B*5701 (and Mamu-B*17) molecules, a smaller diversity
of self-peptide TCR contact sequences will be encountered by HLA-B*5701/Mamu-
B*17-restricted T cells in the thymus1 .
4.2 Thymic selection against fewer types of self
peptides results in a more cross-reactive T-cel
repertoire
The diversity of self peptides presented in the thymus shapes the characteristics of
the mature T-cell repertoire. Experiments (Huseby et al., 2006, 2005) and theoretical
studies (Chapters 2 and 3 and (Kosmrlj et al., 2008, 2009)) show that T cells that
develop in mice with only one type of peptide in the thymus are more cross-reactive
to point mutants of peptide epitopes that they recognize than T cells from mice
that express diverse self peptides. Thus, by encountering fewer self peptides during
thymic development, HLA-B57-restricted CD8+ T cells should be more cross-reactive
to point mutants of targeted viral peptides.
'Our study showed that the protective allele HLA-B*5701 binds fewer peptides derived from hu-
man proteome compared to other alleles (Table B.1). Even if the reason why HLA-B*5701 molecules
bind fewer self peptides was due to greater restrictions in the tolerance to different amino acids at
the anchor residues only, HLA-B*5701 molecules would present a smaller diversity of TCR contact
residues in the thymus. This is because the number of self peptides presented in the thymus is
much smaller than all possible sequences of TCR contact residues derived from the human pro-
teome. Thus, the probability that any HLA allele presents peptides derived from different parts
of the proteome with identical TCR contact residues constrained by the same anchor residues is
small. Therefore, since HLA-B*5701 presents fewer self-peptides, T cells restricted by this allele will
encounter a smaller diversity of TCR contact residues during development in the thymus.
We carried out in silico thymic selection experiments to test this hypothesis. We
chose an HLA-dependent number of thymic self peptides, each with amino acids of
the TCR contact residues picked according to the frequency with which they appear
in the human proteome (Table 2.1 and (Hubbard et al., 2009; Kosmrlj et al., 2008)).
A diverse set of immature CD8+ T cells (thymocytes) was generated by choosing
the sequences of their peptide contact residues in the same way, and by varying
the TCR-HLA interactions. A thymocyte emerges from the thymus as a mature
CD8+ T cell if its TCR binds to at least one self-peptide-major histocompatibility
complex (pMHC; human MHC is called HLA) molecule with an affinity that exceeds
the positive selection threshold, and does not interact with any pMHC more strongly
than the negative selection threshold. Using a computational model (Chapters 2 and 3
and (Kosmrlj et al., 2008, 2009)) in the class of string models (Chao et al., 2005), we
assessed the affinity of TCR-self-peptide-HLA complexes to determine which T cells
survive positive and negative selection, and become a part of the mature repertoire.
Our qualitative results are independent of the parameters used to determine these
interaction strengths (see Chapters 2 and 3, Appendix A and (Kosmrlj et al., 2008,
2009)).
The mature T cells that emerged from these in silico thymic selection experi-
ments were then computationally challenged by a viral peptide (that is, not seen in
the thymus) bound to the same HLA type. T cells that recognize this peptide-HLA
complex were obtained by assessing whether the interaction strength exceeded the
negative selection threshold (shown to be equal to the recognition threshold in mouse
models (Naeher et al., 2007)). Cross-reactivity of these T cells was then determined
in silico by mutating each TCR contact residue of the peptide to the other 19 possi-
bilities. Sites on the viral peptide were called important contacts if half the mutations
therein abrogated recognition by T cells that target this epitope. The frequency of the
number of important contacts in viral peptides that determine T-cell recognition was
obtained by repeating this procedure 1,000 times with different choices of thymocytes
and self and foreign peptides.
Our calculations predict that a T-cell repertoire restricted by an HLA molecule
such as HLA-B*5701, which presents fewer self peptides in the thymus, has a higher
frequency of occurrence of T cells that recognize viral peptides through smaller num-
bers of important contacts (Figure 4-1a). In contrast, the frequency of occurrence of
T cells that recognize viral peptides through many important contacts is larger for
repertoires restricted by HLA alleles that present a greater diversity of self peptides
in the thymus (data not shown for >4 contacts). Mutations at sites different from the
important contacts do not affect binding strength substantially. Therefore, when the
interaction between peptide-HLA and TCR is mediated by fewer important contacts,
a larger number of possible point mutations of the peptide do not affect peptide recog-
nition, thereby making the T cells more cross-reactive to mutants that arise. Thus,
the HLA-B57-restricted T-cell repertoire is expected to be more cross-reactive to mu-
tants of targeted viral peptides than repertoires restricted by HLA alleles that present
a greater diversity of self peptides.
Our computational models give this qualitative mechanistic insight, but do not
provide quantitative estimates of the extent of this enhanced cross-reactivity of T
cells. However, compelling experimental data (Turnbull et al., 2006) has shown that
the effect revealed by our studies is important in humans. Peripheral blood mononu-
clear cells from patients expressing HLA-B57 contained CTLs that were more cross-
reactive to various HIV epitopes and their point mutants than those of HLA-B8-
positive patients. HLA-B8 is associated with rapid progression to disease (Turnbull
et al., 2006), and the most accurate algorithm for peptide binding suggests that the
HLA-B8 molecule binds a greater diversity of self peptides than HLA-B57 (Figure B-
2 and Table B.1). Other experimental studies also show that patients expressing
HLA-B57 cross-recognize point mutants of the dominant epitope and use more public
TCRs (i.e. cross-reactive TCRs present in more than one person; (Gillespie et al.,
2002; Yu et al., 2007)).
Next, we computed interaction strengths between diverse viral peptides and mem-
bers of T-cell repertoires restricted by HLA molecules that present differing numbers
of self peptides in the thymus. This allowed us to obtain the probability with which
a randomly picked T-cell clone and viral peptide will interact sufficiently strongly for
a b
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Figure 4-1: Thymic selection against fewer self peptides leads to a more cross-reactive
T-cell repertoire. (a) Histogram of the frequency with which T cells recognize viral
peptides (that is, not seen in the thymus) through only a small number (0, 1, 2, 3)
of important contacts (see text) is shown for three T-cell repertoires that developed
with different numbers of self-peptide-HLA complexes in the thymus. If the TCR-
peptide-HLA interaction is sufficiently strong, no single point mutation can abrogate
recognition, resulting in zero important contacts. A higher frequency of occurrence of
a small number of important contacts indicates a more cross-reactive T-cell repertoire
because only mutations at these contacts are likely to abrogate recognition. (b) The
probability that a TCR binds to viral peptides with a certain interaction strength is
shown for three T-cell repertoires. A particular TCR recognizes a viral peptide when
the binding strength exceeds the recognition threshold (dashed black line). Members
of a T-cell repertoire selected against fewer self peptides are more likely to recognize
a viral peptide. The model we used describes qualitative trends robustly (Chapters 2
and 3 and (Kosmrlj et al., 2008, 2009)), but is not meant to be quantitatively accurate.
This figure is adapted from Figure 1 in (Kosmrlj et al., 2010).
recognition to occur. The results (Figure 4-1b) indicate that a typical CD8+ T cell
restricted by an HLA molecule such as HLA-B*5701, which presents fewer peptides
in the thymus, has a higher probability of recognizing a viral epitope compared to a
T cell restricted by other HLA molecules. Thus, more HLA-B*5701-restricted T cell
clones are likely to recognize a viral epitope, making effective precursor frequencies
higher in an HLA-B*5701-restricted repertoire (a strong predictor of response mag-
nitude (Moon et al., 2007)). A greater precursor frequency for viral epitopes in the
naive repertoire restricted by HLA-B57 is indicated by experimental results showing
that HLA-B*5701 contributes the most to acute-phase CTL responses of all HLA
alleles tested (Altfeld et al., 2006).
The results in Figure 4-1 stem from the constraint that thymocytes must avoid
being negatively selected by each self-peptide-HLA complex encountered during de-
velopment in the thymus. T cells expressing TCRs with peptide contact residues
composed of amino acids that interact strongly with other amino acids (for example,
charged residues, flexible side chains) have a high probability of binding to a self
peptide strongly. The greater the diversity of self peptides presented in the thymus,
the higher the chance that a TCR with such peptide contact residues will encounter a
self peptide with which strong interactions will result in negative selection. Thus, as
the diversity of self peptides presented in the thymus increases, the peptide contact
residues of TCRs in the mature T-cell repertoire are increasingly enriched in weakly
interacting amino acids (shown analytically in Figure 3-2 and numerically in Figure A-
8). T cells bearing TCRs with weakly interacting peptide contact residues recognize
viral peptides by means of several moderate interactions, making many contacts im-
portant for recognition. In contrast, TCRs with peptide contact residues containing
strongly interacting amino acids are more likely to recognize viral peptides through a
few important contacts mediated by these residues, making recognition cross-reactive
to mutations at other peptide sites. These mechanistic insights are supported by
experimental results (see Chapter 2 and (Huseby et al., 2006; Kosmrlj et al., 2008)).
4.3 Cross-reactivity of T cell repertoire correlates
with the control of HIV infection.
By studying a model of host-pathogen dynamics 2 that builds on past models of
host-HIV interactions (Althaus and de Boer, 2008; Nowak et al., 1995; Wodarz and
Thomsen, 2005), we explored the consequences of the HLA-B57-restricted CD8+ T-
cell repertoire having a higher precursor frequency for viral peptides, and being more
cross-reactive to point mutants of targeted epitopes on the control of HIV. Because of
the importance of immune control exerted by CD8+ T cells (Altfeld et al., 2006; Cao
et al., 2003), we focused on the interaction between a mutating virus quasispecies and
2 The model of host-pathogen dynamics was developed by Elizabeth Read.
To.DCfl 1 expansion
Figure 4-2: Dynamic model of host-pathogen interactions: the virus mutates, infects
limited-target CD4+ T cells, and is cleared. Infected CD4+ T cells produce more free
virus and die. Infected cells present viral peptides in complex with HLA molecules
(until peptides unbind from HLA). Activated CD8+ T cells produced by recognition
of viral epitopes on antigen-presenting cells (APCs) proliferate and differentiate into
effector CTLs. CTLs kill infected cells bearing cognate peptide-HLA complexes, and
turn into memory cells that are activated after re-exposure to antigen. This figure is
adapted from Figure 2a in (Kosmrlj et al., 2010).
epitope-directed, variably cross-reactive, host CTL responses.
The essential features of the model are depicted in Figure 4-2 (details in Ap-
pendix C). The virus is modelled as a number of epitopes consisting of strings of
amino acids, and new viral strains (point mutations of epitopes), which differ in
replicative fitness, arise over the course of infection. For each individual, an HLA-
dependent CD8+ T-cell repertoire was chosen. To mimic the results obtained from
our thymic selection calculations (Figure 4-1b), more or less cross-reactive repertoires
were chosen (Figure C-1) to represent HLA-B57-restricted T cells and those restricted
by other HLAs, respectively. Infection rates were limited by target CD4+ T cells, and
CTL contraction and memory were included. Other dynamic models were studied,
including one that does not incorporate target cell limitation or CTL contraction.
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Figure 4-3: Simulated HIV viral loads versus time for different cross-reactivities (CR)
of the CD8+ T-cell repertoire (the black and red curves correspond to high and
low cross-reactivity respectively). Each curve is averaged over 500 simulations (each
simulation represents a person). The model shows a reduced set-point viral load for
people with a more cross-reactive T-cell repertoire. Other models of host-pathogen
dynamics show similar effects of T-cell cross-reactivity (Figures C-2 and C-3). This
figure is adapted from Figure 2b in (Kosmrlj et al., 2010).
parameters and model assumptions (Figures C-2 - C-11).
We find that individuals with a more cross-reactive CTL repertoire control viral
loads better during the acute phase of the infection (Figure 4-3). This is in agreement
with findings in simian immunodeficiency virus (SIV)-infected rhesus macaques (Price
et al., 2009), where the number of cross-reactive TCR clones negatively correlates
with viral load. Our simulations show that a larger number of CTL clones in a more
cross-reactive T-cell repertoire recognize epitopes from the infecting viral strain (Fig-
ure 4-4). This is because the predicted higher precursor frequency for viral epitopes
(Figure 4-1b) leads to a greater response magnitude (as in mouse models (Moon et al.,
2007)). This conclusion is supported by data showing that in people with a protective
HLA allele, the initial T-cell response to HIV is dominated by T cells restricted by
the protective HLA and not those restricted by other HLAs expressed (Altfeld et al.,
2006). Our simulations also show that enhanced cross-reactivity of the T-cell reper-
toire leads to greater immune pressure on the emergent viral mutants by individuals
high cross-reactivity low cross-reactivity
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Figure 4-4: Virus diversity and immune pressure for representative people (that is,
representative simulations) with high cross-reactivity (left) and low cross-reactivity
(right) of CD8+ T-cell repertoires. Top panels show the relative population sizes of
two dominant viral strains: the infecting strain (black), and an emerging, less fit strain
(green) (other less populous viral strains are not shown). For people with a more cross-
reactive T-cell repertoire, the emergent mutant strain only begins to dominate the
infecting strain after 175 days, whereas for low cross-reactivity the mutant increases
to nearly 100% of the viral population within 100 days after infection. Bottom panels
show the relative immune pressure, defined as the rate of killing of an infected cell
(see Equation (C.3) and description in Appendix C), imposed on each viral strain
by different CD8+ T-cell clones. Each curve represents the relative immune pressure
exerted on that viral strain by a particular T-cell clone. For people with a more
cross reactive T-cell repertoire, several T-cell clones exert immune pressure on both
the infecting and emergent strains. For people with a low-cross-reactivity T-cell
repertoire, the emergent strain is not recognized, and thus escapes. This figure is
adapted from Figure 2c in (Kosmrlj et al., 2010).
expressing HLA-B57 compared to those with T cells restricted by HLA molecules
that bind more types of self peptides. The stronger immune pressure on infecting
and emerging viral strains results in superior control of viral load. Thus, we predict
that HIV-infected individuals with HLA alleles that bind fewer self peptides are more
likely to control viral loads to low values.
To test this prediction, we studied two large HLA-typed cohorts: 1,110 controllers
with less than 2,000 HIV particles ml- 1 and 628 progressors (or non-controllers) with
viral loads exceeding 104 ml-1. From these data, we obtained the odds ratio (OR)
Table 4.1: Alleles with significant association of HIV control or progression
allele OR 95% confidence interval p value
HLA-B*0702 1.90 [1.41, 2.56] 1 x 10-3
HLA-B*2705 0.45 [0.30, 0.67] 3 x 10-3
HLA-B*3501 1.95 [1.38, 2.76] 7 x 10-3
HLA-B*5701 0.28 [0.19, 0.42] 1 x 10-8
HLA-B*5703 0.13 [0.07, 0.26] 2 x 10-7
for individual HLA alleles. The odds ratio (OR) for an allele is defined as: Pw/P,cw/clvO
where pw and pwo are the numbers of individuals in the progressor cohort with and
without this HLA, respectively; and c, and c,0 are the numbers of individuals in the
controller cohort with and without this HLA, respectively. This definition suggests
that the OR measures the likelihood of an allele being correlated with progressors
versus controllers, with an OR greater (less) than one indicating association with
the progressor (controller) cohort. We focused on HLA-B alleles because they are
associated with control of HIV (Kiepiela et al., 2004). Of 40 HLA-B alleles that were
studied, significant results (P value < 0.05)3 were obtained for five HLA-B alleles
(Table 4.1) and peptide-binding data are available for four of them. In support of our
predictions, those HLA-B alleles associated with higher OR values also bind more self
peptides (Figure 4-5).
Superior control of viral load due to the greater precursor frequency and cross-
reactivity of those T-cell repertoires restricted by HLA molecules that bind to few self
peptides (for example, HLA-B57) should also confer protection against diseases caused
by other fast-mutating viruses. Indeed, HLA-B57 is protective against hepatitis C
3 HLA-allele association with ability to control HIV. SAS 9.1 (SAS Institute) was used for data
management and statistical analyses. Odds ratios and 95% confidence intervals were determined
using PROC LOGISTIC in a comparison of HIV controllers (those individuals who maintained viral
loads of less than 2,000 copies of the virus per ml plasma on three determinations over at least a
year of follow-up and, on average, for approximately 15 years (Pereyra et al., 2008)) to HIV non-
controllers (those individuals whose viral loads exceeded 10,000 copies of the virus per ml plasma).
To eliminate the confounding effects of HLA-B*0702, HLA-B*3501, HLA-B*2705 and HLA-B*5701,
alleles strongly associated with progression or control, these factors were used as covariates in the
logistic regression model for the analysis of all other HLA class I types (Hosmer et al., 1989).
All ethnic groups were included in the analyses shown (European, African-American and others)
and we adjusted for ethnicity in the logistical regression model. All P values were corrected for
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Figure 4-5: HLA-B alleles associated with greater ability to control HIV correlate with
smaller self-peptide binding propensities. This definition suggests that the OR mea-
sures the likelihood of an allele being correlated with progressors versus controllers,
with an OR greater than one indicating association with the progressor cohort. Peo-
ple with HLA alleles associated with an OR value greater or less than one are more
likely to be progressors or controllers, respectively. The fraction of peptides derived
from the human proteome that bind to a given HLA allele was determined using the
most accurate predictive algorithms (Table B.1). Compared to experimental data,
the predictive algorithms for peptide binding by HLA-B*3501 are less accurate than
algorithms for the other three alleles (Figure B-3 and Table B.1); the number re-
ported here for HLA-B*3501 using the most accurate algorithm underestimates the
binding fraction. The error bars represent the 95% confidence intervals for OR. The
dotted line corresponds to equal odds for an allele being associated with progressors
and controllers. This figure is adapted from Figure 3 in (Kosmrlj et al., 2010).
virus, HCV (Thio et al., 2002), another highly mutable viral disease in which CD8+
T cells are important. Also, HLA-B8, which binds a greater diversity of self peptides,
is associated with faster disease progression in HCV (McKiernan et al., 2004) and
HIV (Turnbull et al., 2006). Thus, the correlation between the diversity of peptides
presented in the thymus during T-cell development and control or progression of
disease may be general.
4.4 Conclusions
Undoubtedly, many complex factors influence the relationship between HLA type and
disease outcome. The effect of the new factor we have identified should be greatest
for HLA molecules that bind relatively few (for example, HLA-B57) or many (for
example, HLA-B7, -B35, -B8) self peptides. The strong association of HLA-B27,
which binds an intermediate number of self peptides (twice as many as HLA-B57),
with viral control indicates that, in this case, the effects of T cell cross-reactivity
are reinforced by this molecule binding HIV epitopes that are subject to very strong
structural constraints.
Our results also point to a mechanistic explanation for as yet unexplained asso-
ciations between HLA alleles that confer protection against HIV and autoimmune
diseases. T cells restricted by HLA alleles that bind to few self peptides are subject
to less stringent negative selection in the thymus, and should therefore be more prone
to recognizing self peptides. Indeed, HLA-B57 has been associated with autoimmune
psoriasis (Bhalerao and Bowcock, 1998) and hypersensitivity reactions (Chessman
et al., 2008). Enhanced cross-reactivity of HLA-B27-restricted T cells and other
unique properties of this molecule (misfolding, homodimers (de Castro, 2007)) proba-
bly contribute to the enhanced risk of autoimmunity associated with this allele (Bow-
ness, 2002).
Our results shed light on another intriguing observation; acutely infected patients
with low viral loads (and protective HLAs) tend to target an immunodominant epi-
tope that makes a larger relative contribution to the total CTL response as compared
to individuals presenting with higher levels of viraemia (Streeck et al., 2009). This is
counterintuitive as the most protective responses appear most focused, rather than
broadly distributed over many epitopes. We calculated how viral load correlates
with the number of CTLs responding to the immunodominant epitope divided by
the total number of CTLs activated by the virus (a quantity analogous to relative
contribution (Streeck et al., 2009)). Mirroring experimental data, HLA alleles that
restrict a more cross-reactive repertoire and are more protective also make a larger
relative contribution (Figure C-8). This result unifies the idea of both a broad and
a focused response. The more cross-reactive repertoire targets more epitopes and
emergent mutants, but a larger number of clones also recognize the dominant epitope
(Figure 4-4).
Cross-reactive T cells are rare in people with HLA alleles that present more self
peptides in the thymus than the B57 allele, but they do exist. Our results suggest
that a T-cell vaccine for a diverse population must aim to activate these rare cross-
reactive T cells that also target epitopes from a conserved region of the HIV genome
(like HLA-B57 Gag epitopes). This will enable robust responses to infecting and
mutant strains until a strain with low replicative fitness emerges, enhancing control
of viral load.
Chapter 5
Thymic selection of T cells as
diffusion with intermittent traps
After bacterial or viral infection, the job of an organism's immune system is to rec-
ognize and eliminate pathogens from the host. T cells orchestrate adaptive immune
responses by recognizing short peptides derived from pathogen proteins, and by dis-
tinguishing them from self-peptides derived from host proteins (Janeway et al., 2004).
To ensure the latter, immature T cells (thymocytes) diffuse around the thymus gland,
where they encounter an ensemble of self-peptides presented on (immobile) antigen
presenting cells (APC) (Hogquist et al., 2005; Palmer, 2003). If a thymocyte binds
strongly to such an APC, it is eliminated; i.e. the APC acts as a trap for the diffusing
thymocyte. Since the peptides presented by APCs are recycled, the traps are not per-
manent, but intermittently turn "on" and "off". Only a few percent of thymocytes
survive thymic selection (van Meerwijk et al., 1997; Merkenschlager et al., 1997), but
these few may cause autoimmune diseases. We are interested in the escape probability
of such "autoimmune" T cells during thymic selection. To address this question, in
this Chapter we study the survival probability of a random walker on a d-dimensional
cubic lattice with randomly placed immobile traps that intermittently switch between
"on" and "off" states. First we review what is known about the survival probability
in a well studied problem where traps are always "on". We then discuss the effect of
This chapter is based on the publication (Kosmrlj, 2011).
intermittent two-state traps on the survival probability at short and long times and
describe a peculiar caging effect at intermediate times when switching between trap
states is slow.
5.1 Classical trapping problem
The problem of trapping in a random medium has been studied extensively, with
applications including dynamical processes in disordered media, kinetics of reactions,
electron-hole recombinations in random and amorphous solids, and exciton trapping
and annihilation (Havlin and Ben-Avraham, 1987; den Hollander and Weiss, 1994).
Here we review what is known about the survival probability of a random walker
in a field of randomly placed immobile traps on a d-dimensional cubic lattice, when
averaged over all random trap configurations. At each step a walker hops from one
site to a randomly chosen nearest neighbor site and if it lands on a trap, it dies.
Suppose that a walker has survived the first n steps, during which it has visited S,
distinct lattice sites. If the trap concentration is c, then the probability that all S"
lattice sites were not traps is equal to (1 - c)Sn. The average survival probability of
a walker after n steps is thus
(DON(n, c) ((1 - C)S") -e ASn) (5.1)
where A - In(1 - c), and the averaging is over all realizations of random walks
of length n. The exact analytical result of survival probability is only known in one
dimension (den Hollander and Weiss, 1994), while analytical approximations in higher
dimensions are only known for small and large n.
At small and intermediate number of steps n, the survival probability is accurately
described by the Rosenstock approximation (Rosenstock, 1970)
AON (n, c) knw . (5.2)
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where P(x; z) = n= - zP (x) is the generating function of the probability distri-
bution P,(x) that a random walker is at location x after n steps. The Rosenstock
approximation can be extended by rewriting the survival probability in terms of cu-
mulants (Zumofen and Blumen, 1982):
In 4ON =ln eAs X:( 1 A n)n, 54
where the first two cumulants are KI(n) (Sn) and K2(n) = (Sn)c = ((Sn - (Sn))2)
For fixed n the series converges rapidly when A is small. This is because 1 < S, <
n + 1, which implies that the jth cumulant, Kj(n) is at most of order ni. The series
is thus expected to converge rapidly when n < A-1. In practice only the first two
terms can be used, because in d > 2 analytical expressions are known only for the
first two cumulants (Montroll and Weiss, 1965; Torney, 1986). To estimate the range
of validity of Rosenstock approximation, we check where A2h2(n) < Ari(n):
d r 1 (n) K2 (n) A2 r 2(n) < AKi(n)
1 ai Vn bin n < (a)2
2 a2 n b2 n"2 n < a ln 3 (_j) (5.5)ln(8n) ln(8n) b2 A A
3 a3n b3n lnn n < exp( )
> 4 adn bdn all n.
Note that the estimate above appears to suggest that for d > 4 the Rosenstock
approximation is valid for all n, but this is not correct as will be described next.
Therefore it is only safe to assume that the Rosenstock aproximation is valid for
n < A-1 .
In the limit of large n, Donsker and Varadhan (Donsker and Varadhan, 1975, 1979)
proved that the survival probability falls asymptotically as a stretched exponential:
(DON(n, c) e kA 2/(d+ 2 )nd/(d+ 2), (5.6)
where kd is numerical constant which depends on dimension d and lattice properties.
For a d-dimensional cubic lattice the value of kd is:
k-(d-i- 2) ( 2 73 da/(d+2)kd = 2-dd(+)(5.7)2 (d)
where -y = j2 W2/d is the lowest eigenvalue of the operator - A for the sphere
2
of unit volume in d dimensions with zero boundary values (absorbing boundary con-
dition), with Wd = 7rd/2/l'(1 + d/2) the volume of a d-dimensional sphere of unit
radius, and (, the smallest zero of the Bessel function of the first kind of order p. The
stretched exponential at large times is a consequence of diffusion through large trap
free regions which appear with exponentially small probability. The correct asymp-
totic result can be obtained also through a simple heuristic argument (Grassberger
and Procaccia, 1982). Since we are interested in long times and large trap free re-
gions we can treat the problem in the continuum limit and replace a random walk
with Brownian motion with diffusion constant D = 1/(2d). The probability that
there are no traps inside a sphere of radius R is (1 - c)'dRd = exp(-AwdRd). The sur-
vival probability of a walker originally at the origin of the sphere satisfies the diffusion
equation with absorbing boundary conditions. At long times the survival probability
is dominated by the normal mode with the slowest decay exp(-nD _1 /R 2 ). The
2
joint probability for there to be a trap-free sphere of radius R, and for the diffusing
walker to stay inside the sphere for at least n steps is thus:
(DON (R, n) = exp [-AwdRd - nD2 _1/R2 . (5.8)
The joint probability is maximized at the radius R = (2nD~d-1/dAwd)1/(d+ 2 ), which
results in
(d + 2) 2 a/(+2 2/(d+2)'4ON (n) ~ exp - -nD ! _ 1 )l(+)(ALL) . (5.9)
Note that this is identical to the Donsker-Varadhan result.
Interestingly, the survival probabilities for different concentrations are connected
through a scaling function (Barkema et al., 2001; Gallos and Argyrakis, 2001b). The
scaling ansatz for a function Fd, which connects the small n (Rosenstock) and large
n (Donsker-Vardahan) limits for all trap concentrations A is:
In GON -- nd Fd (Anad) , (5.10)
with Fd(x) - adX for small x and Fd(x) - kdx2/(d+2) for large x. Exponents ad =
(d - 2)/d and 13d= 2/d for d > 3 (ai = 0, 13, = 1/2) are chosen such that the survival
probability satisfies equations (5.2) and (5.6) for small and large n. In two dimensions
logarithmic factors must be added to the scaling function to account for logarithmic
factors in the Rosenstock regime, resulting in
ln(DON= - ln(8n)F2  n (5.11)(In 2(8n)
The transition from Rosenstock to Donsker-Varadhan regime occurs at adxd*~
kdXd 2/(d+2), where x* - An*fd . The values x* for the first three dimensions are x*
27r 7 /2 /(128v/2) ~ 8.2, * = Q/ir ~ 1.84 and xz = (55 8P(O; 1)5/2138)1/3 ~ 26.3,
which are slightly bigger then the ones reported by numerical simulations (Barkema
et al., 2001). Note that for d > 2, the survival probability at the transition depends
on the trap concentration, and except for the densely trapped cases of c ~ 1, the sur-
vival probability at the transition is too small for the Donsker-Varadhan limit to be
observed by direct numerical simulations of random walks (den Hollander and Weiss,
1994). Several numerical techniques have been developed that allow exploration of
the Donsker-Varadhan limit, e.g. by exact enumeration of clusters of non-trapping
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Figure 5-1: Collapse of survival probabilities: Numerical simulations of the survival
probability <bON for different trap concentrations for d = 1, 2, 3 obey the scaling shown
in equations (5.10) and (5.11). Colored solid lines from left to right correspond to
c = 10-5 (dark blue), 10-1, 103, 102, 10-1, 0.5,0.9,0.99 (dark red). The Rosenstock
approximation (dashed green line) works well at small A and n, while the Donsker-
Varadhan limit (dashed black line) is reached only in one dimension. In two and three
dimensions only the early stages of the transition to the long time limit are seen. For
clarity, results for different dimensions d are shifted as indicated by the vertical axis
label. This figure is adapted from Figure 1 in (Kosmrlj, 2011).
rakis, 2001a), mapping to a polymer model (Barkema et al., 2001), and mapping to
self-avoiding random walks (Gallos and Argyrakis, 2001b).
Figure 5-1 summarizes all results for the survival probability from this section. We
calculated survival probabilities at different trap concentrations ranging from c = 10-5
to c = 0.99 by directly simulating random walks and averaging over different trap
configurations. Survival probability curves for different concentrations collapse on a
single curve confirming the scalings from equations (5.10) and (5.11). The Rosenstock
approximation works very well for small values of x, except for very small n, where
the asymptotic limit of (Sn) is not yet reached. The Donsker-Varadhan limit is only
observed in one dimension, while in two and three dimensions only the early stages






Figure 5-2: Model. A random walker (black circle) steps on a lattice with randomly
placed immobile traps. At each step a walker hops to a randomly chosen nearest
neighbor site. If it steps on a trap in an absorbing "on" state (red), it dies, while if it
attempts to step on a trap in a "reflective" state (blue) it remains at the initial site.
Traps stay in the "on" ("off") state for typical time nON (nOFF) before switching to
the other state. This figure is adapted from Figure 2 in (Kosmrlj, 2011).
5.2 Intermittent traps
In the previous section we discussed a classical trapping problem in which traps are
always in the absorbing ("on") state. In this section the second reflective ("off") state
is added to the model (Figure 5-2). If a random walker attempts to step on a trap
in the "off" state it remains at the initial site, while it dies if it attempts to step on
a trap in the "on" state. Switching times of trap states are exponentially distributed
random variables, with traps staying in the "on" ("off") state for characteristic time
nON (nOFF). The probability that a trap is initially in the state x ("on", "off") is
pX = nx .(5.12)
nON + nOFF
To numerically obtain survival probabilities, we directly simulate the process. We
start with a large d-dimensional lattice grid (containing ~ 1010 lattice points) that
is divided into smaller hypercubes, each of which contains ~ 1000 lattice points.
The grid is large enough that a random walker is always trapped before reaching the
edges of the grid. To save computation time, a random configuration of traps inside
a hypercube is generated only after a random walker first enters that hypercube. The
state of each trap is determined only after the random walker tries to jump on it and
the state is chosen according to the probabilities in equation (5.12). After that the
trap switches between the states with random exponentially distributed switching
times. We simulate a random walk and measure how long the walker stays alive.
This process is repeated many times with different trap configurations to obtain the
survival probability 4(n, c, nON, nOFF) after n steps with trap concentration c.
What is the survival probability 4 of a random walker in this case, and how is it
related to 4DON where traps are turned "on" all the time? The survival probability D is
bounded from below by 4DON, because having all traps "on" increases the probability
of trapping
4 ON. (5.13)
At large number of steps n in the Donsker-Varadhan limit, the survival probability is
dominated by large trap free regions. The slow step is diffusion through this region,
while finding the trap in an "on" state outside this region is quicker. Therefore at
large n
4 1ON. (5.14)
For small n and low trap concentrations c (c(Sn) < 1), the probability of trapping
(1 - 4D) is dominated by the first collision with a trap, which must be turned on:
1 - 4 ~PON(1 - (DON ). (5.15)
Figure 5-3 shows survival probabilities in d = 1, 2, 3 for different values of nON and
nOFF. The trapping relation (Equation 5.15) works well at short times n. Crossover
to the long time Donsker-Varadhan limit (5.14) is seen only in one dimension and the
transition is slower in higher dimensions. When switching times nON and nOFF are
slow we notice that the survival probability plateaus at some level, before it starts
dropping again. The reason for this is a caging effect described below.
In d = 1 a random walker is always bounded by the nearest left and right traps.
When switching between trap states is very slow, the trap configuration is "frozen"
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Figure 5-3: Survival probability (D in d = 1, 2, 3 (c = 0.1, nOFF/nON = 1). Colored
solid lines correspond to different values of nOFF; the darkest red color on the right
corresponds to the largest nOFF = 107 and neighboring curves differ by factors of 10
in nOFF. For small n, the trapping relation (Equation 5.15, dotted green line) works
well. (DON (solid black line) represents a lower bound for 4, which is reached in the
Donsker-Varadhan limit of large n. Crossover to the Donsker-Varadhan limit is slower
in higher dimensions. When switching times nON and nOFF are slow (yellow, orange,
red) the survival probability plateaus before it starts dropping again. This figure is
adapted from Figure 3 in (Kosmrlj, 2011).
for n < nON, nOFF. If at least one of the bounding traps is in "on" state, a random
walker dies at that trap. With probability p2FF both bounding traps are in the "off"
state, forming a cage. The walker diffuses inside this cage until one of the traps turns
"on" and then it is quickly absorbed. The "survival" probability of the cage is:
cD(n) = pOFF exp[-2n/rOFF], (5.16)
where the exponential factor represent the probability that both bounding traps are
still in the "off" state after n steps. After the survival probability 4 of a walker drops
to the probability of caging, it is well approximated by the above equation (Figure 5-
4a). Ic decays faster than the stretched exponential in the Donsker-Varadhan limit,
which comes from large trap free regions. Therefore at large n the survival probability
is still dominated by the large trap free regions (Figure 5-3).
In d > 1 traps always form a cage when the trap concentration c is above the
percolation threshold. However, even at low trap concentration c, with low probability
there are some trap configurations that form small cages around the origin. If at least
one of the traps forming a cage is in the "on" state, then a random walker dies quickly.
But if all cage forming traps are in the "off" state, and the typical switching time
nOFF is slow, then a random walker diffuses inside the cage until one of the traps
switches to the "on" state. The average survival probability of a random walker that
is caught in a cage is thus
<Dc = E (Ak(l -c)kct) x (pOFF exp--fn/nOFF]), (5.17)
where f is the number of traps forming a cage, and k the number of empty sites inside
the cage excepting the origin (because the origin - the initial location of the random
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Figure 5-4: Caging effect: a) Survival probabilities in d = 1 (c = 0.1, nOFF/nON = 1)
agree well with the probability of caging (Equation 5.16, dashed yellow line) when
switching times are slow (colored solid lines in a) and c) are the same as in Figure 5-
3). The solid yellow line is initially close to the probability of caging, but at large n it
starts deviating and approaches the stretched exponential of the Donsker-Varadhan
limit. b) Configuration of cages in d = 2 with the smallest number f of cage forming
traps. A random walker (black) sits at the origin and is surrounded by traps in the
"off" state (blue). Ae,k gives the number of equivalent cage configurations. c) Survival
probabilities in d = 2 (c = 0.8, nOFF/nON = 10) agree well with the probability of
caging (Equation 5.17) when switching times are slow. For large n it is sufficient to
keep only one (dashed red line) or two (dashed black line) terms in Equation (5.17).
Because c = 0.8 and POFF = 10/11 are close to 1, more terms need to be kept for
accurate description of the caging probability at small n (dotted yellow line, up to




walker - is always assumed to be empty). The first factor represents the probability
of cage formation with Ae,k being the combinatorial number of configurations with
the same number of empty sites and cage forming traps. The second factor is the
probability that all cage forming traps are initially in the "off" state and remain
in the same state for n steps. In d = 2, the first few non-zero coefficients A,k are
A 4,0 = 1, A6 ,1 = 4, A7,2 = 12 (Figure 5-4b) and in general for d > 1 the first two
non-zero coefficients are A2d,o = 1 and A4d-2,1 = 2d. When c or POFF are small, or
n >> nOFF, it is enough to keep only the first few terms in equation (5.17), but if c and
POFF are close to 1 and n , nOFF then we must keep more terms (Figure 5-4c). Like
in one dimension, the survival probability 4 is well approximated for large nOFF by
equation (5.17) after D drops to the probability of caging Ic. Fc decays faster than
the stretched exponential decay in the Donsker-Varadhan limit; therefore at large n
the survival probability should still approach (DON (Figure 5-3).
5.3 Escape probability of autoimmune T cells
In conclusion, let us return to the question of escape probability of potentially autoim-
mune T cells from the thymus. First we estimate the relevant parameters in our model.
The density of APCs in the thymus is 30,000-50, 000 cells/mm3 (Borgne et al., 2009).
If we choose the lattice constant ao to be equal to the typical diameter of the antigen
presenting cell ~ 10pm (Borgne et al., 2009), the trap concentration is estimated at
c ~ 0.03-0.05. From the T cell diffusion constant, D ~ 100pm 2min-' (Borgne et al.,
2009), we estimate the hopping time of a random walker as ti = a2/(6D) - 0.2min.
T cells diffuse around the thymus for around 4-5 days (Klein et al., 2009), which
is equivalent to n ~ 30, 000-40, 000 steps of a random walker. A typical lifetime of
a self-peptide on the surface of APCs is on the order of hours (Henrickson et al.,
2008), which corresponds to nON - 100- Since many self-peptides are simultaneously
presented on the surface of APCs, the effective nON could be even longer. Differ-
ent T cells are represented with different nOFF. A potentially autoimmune T cell
is more likely to bind strongly to APCs and is thus associated with lower values of
nOFF. Let us first estimate the escape probability for an extremely autoimmune T
cell, which reacts to every host cell. Such a T cell is characterized by nOFF= 0 and
= -ON. Since x = An2/3 - 30-60 is larger than the location x= 26 of the transi-
tion to the Donsker-Varadhan limit, we use the Donsker-Varadhan result to estimate
4ON , 10-400_10-300. This implies that an extremely autoimmune T cell cannot
escape from the thymus.
In reality autoimmune T cells do not react to every host cell, but are directed
toward particular tissues. Since tissue specific peptides are presented on 1-3% of
APCs in the thymus (Klein et al., 2009), such autoimmune T cells are characterized
by nOFF - 3, 000-10, 000 in our model (PON - 1-3%). The model estimates that
the escape probability of T cells specific for tissues that are represented with fewer
peptides (PON - 1%) is 6 10- -0-3 and the escape probability of T cells specific for
tissues that are represented with more peptides (PON 3%) is 1020_10- 10. The
estimates are very crude, because the survival probability depends exponentially on
the parameters which are just approximately determined. However, we still see that
the escape from the thymus is possible when tissue specific peptides are not presented
in big amounts. This may be why the immune system contains specialized regulatory
T cells, which try to shut down the response from autoimmune T cells.
Finally, we note that the caging effect is not relevant for thymic selection: since
the trap concentration c is low, even small cages appear with very small probability
and thus the caging effect is not important on the relevant time scales. In any case,
T cells can never be trapped inside cages, as they are delivered to the thymus via
blood vessels and small cages around the entrance would completely block the flow
of T cells through the thymus.
In this paper we introduce to study properties of a model initially motivated by
T cell survival. While the main body of the text explores the full parameter range
of this model, some of the results do not apply to the relevant parameters for the
thymic selection. Furthermore for thymic selection the model parameters are only
approximately known. Because the escape probability of autoimmune T cells depends
exponentially on these parameters, we can only determine the order of magnitude for
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In this thesis, I presented studies that enable an understanding of how the develop-
mental processes in the thymus shape the T cell repertoire such that adaptive immu-
nity exhibits both remarkable pathogen specificity and the ability to combat myriad
pathogens. We proposed a statistical mechanical model of thymic selection which sug-
gests that the peptide binding residues of selected T cell receptors are enriched with
weakly interacting amino acids; a result that is in agreement with available receptor
structures (Chapters 2 and 3 and (Kosmrlj et al., 2008, 2009)). Sufficiently strong
binding for T cell receptor recognition of a foreign peptide is thus achieved via many
moderately strong bonds, each of which makes a significant contribution to binding,
again consistent with experiments (Huseby et al., 2006). Breaking any of these bonds
by mutating the foreign peptide may reduce the binding strength and prevent recog-
nition from the same T cell receptor, because the binding strength falls below the
sharp threshold for recognition. In this sense, T cell receptors are specific for the
foreign peptide and do not recognize the peptide after single amino acid mutations.
Once T cell receptors recognize foreign peptides in this statistical fashion, then the
interaction can persist to allow enough time for possible modest induced fit changes
in T cell receptor conformation to stabilize the interaction even further (Gakamsky
et al., 2007; Wu et al., 2002).
The thymic selection model has some implications also for human diseases. Most
people express different sets of MHC types, and people expressing a particular MHC
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type are genetically predisposed for certain diseases. In particular people expressing
the HLA-B57 type of MHC molecule are more likely to control the HIV infection
even without therapy, but they are also more prone to autoimmunity. Undoubtedly
there are many reasons for this tendency, but we explored only the effect of thymic
selection (Chapter 4). Our bioinformatics study showed that the HLA-B57 molecule
binds fewer types of self peptides compared to other MHC molecules. In agreement
with experiments, our thymic selection model suggests that in these people T cell
repertoires are more cross-reactive, and are more effective at recognizing the mutating
viral peptides. At the same time, more cross-reactive T cells are also more likely
to trigger against self peptides, because the thymic selection is not perfect. We
predicted that MHC molecules that bind fewer (more) peptides are better (worse)
for the control of HIV. Our collaborators tested this prediction on a large cohort of
HIV infected people and our prediction seems to be valid for the MHC types that
bind very few or bind a lot of self peptides (Chapter 4 and (Kosmrlj et al., 2010)),
while for people with other MHC types other effects might be more relevant to HIV
control. Thus we have identified one new effect in people expressing HLA-B57 that
could help them control the HIV infection; undoubtedly other effects also contribute
to these individuals' ability to control HIV.
In the future it would be important to test the combined effect of MHC types (each
human inherits one HLA-B type from mother and one from father) on the control of
HIV. Even though T cell receptors interact productively with only one MHC type,
the dynamics of T cells are coupled through an MHC competition for peptides and a
competition for the presentation of peptide-MHC complexes on the surface of infected
cells. The combined effect of MHC types could be studied, by adapting the host-
pathogen interaction model presented in this thesis. The literature (Carrington et al.,
1999) report that the homozygosity of MHC types (inherited HLA-B types are the
same) speeds up the progression to AIDS. The progression to AIDS is especially fast
when a human inherits non-protective HLA-B35 type from both parents. It would
be interesting to study what are the effects of combinations of protective/protective,
non-protective/non-protective, and especially protective/non-protective MHC types
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on the control of HIV.
Common vaccination strategies are infection with a live crippled virus or usage of
mosaic vaccines (cocktail of viral peptides). Immune system clears the vaccine and
generates a pool of memory T cells, which are specific for viral/vaccine peptides. Upon
viral infection these memory T cells generate faster and stronger immunological re-
sponse. By combining the T cell development model and the model of host-pathogen
interaction, we could study the efficiency of different mosaic vaccines and identify the
optimal combination of viral peptides used in vaccines.
T cells that could potentially target healthy host cells are eliminated during the
thymic selection. However, the flexible adaptive immune system can also go awry,
and many diseases (e.g., multiple sclerosis and type I diabetes) are the consequence of
the T cells failing to discriminate between markers of self and non-self. The suffering
caused by autoimmune diseases and the need to combat diverse infectious agents have
motivated a great deal of experimental research aimed toward understanding how
the adaptive immune system is regulated, and indeed, some spectacular discoveries
have been made. Yet, an understanding of the mechanistic principles that underlie
an autoimmune response remain elusive. This is especially true with regard to the
origins and triggers of autoimmune diseases. Some insights could be obtained by
using statistical mechanics tools, similar to the ones developed in this thesis. For
example:
o By adapting the thymic selection model, to include the variability in expression
levels of different types of self peptides in the thymus, one could get insight into
questions, such as: What leads to a higher frequency of escape of autoreactive
cells which target cells of the nervous system and the pancreas in the case of
autoimmune diseases like multiple sclerosis and type I diabetes? Why are the
escaping autoreactive cells attacking only particular tissues?
o Autoimmune diseases are correlated to a combination of genetic and environ-
mental factors. People who express certain genes have a higher propensity for
certain autoimmune diseases, but not everyone with these genes develops dis-
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ease; e.g., most people with ankylosing spondylitis express HLA-B27 (a type
of MHC), but most people expressing HLA-B27 do not develop ankylosing
spondylitis. Certain genes and viral infections are known to increase the risk
of triggering multiple sclerosis. Insights into these puzzles could emerge from
stochastic dynamical models of host-pathogen interactions coupled with models
of T cell development.
e Why are frequencies of expressed HLA molecules different among different geo-
graphical populations? What gives certain HLA molecules a selection advantage
in populations with different environments and history? This problem could be
studied by adapting the stepping-stone model of spatio-temporal evolution in
population genetics (Kimura and Weiss, 1964).
Many problems in immunology at the molecular, cellular, and organism level re-
main unsolved and present future research opportunities. However, a key challenge
just beginning to be addressed is the following. Much progress (theoretical and exper-
imental) has been made to describe host-pathogen dynamics in humans (especially in
the context of HIV). Basic molecular and cellular immunology has focused largely on
experimental models that are inbred mice or cell lines. This is because these models
can be readily manipulated to test ideas (such as predictions emerging from statistical
mechanical theory and computation). A fundamental challenge is to bridge the gap
between basic molecular discoveries and the immune response of individual humans
with specific genes (e.g., people have diverse MHC genes). Much is to be gained by
making the two meet, and understanding the effects of fluctuations in host genetics
is an interesting statistical mechanics problem.
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Appendix A
Robustness of the thymic selection
model
In this appendix we demonstrate a robustness of the results of the thymic selection
model presented in Chapter 2 to variations of model parameters, such as the inter-
action potential J (Figures A-1-A-4), the softness of positive and negative selection
thresholds (Figure A-5), amino acid frequencies of self peptides and TCRs (derived
from human vs mouse proteome, Figure A-6), TCR binding strengths to MHC (Fig-
ures A-7). Additionally we show how the results depend on the number of self peptides
in the thymus (Figure A-8) and how the selection probability of TCRs depend on its
binding strength to MHC (Figure A-9). We also show that the results of the analy-
sis of TCR-pMHC crystal structures are robust to the definition of contact between
amino acids on the peptide and TCR (Figure A-10).
A.1 Robustness to changes in interaction poten-
tial.
In all calculations reported in Chapter 2, the MJ matrix (Miyazawa and Jernigan,
1996) was used to determine the interaction free energy between peptide contact
residues of the TCR and peptide amino acids. Here, we explore what happens if we
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Figure A-1: Amino acid frequencies in selected TCRs for the MJ matrix J. (a)
Color representation of the MJ interaction matrix in units of kBT. (b) Amino acid
frequencies in selected TCRs for selection against different numbers of self peptides
M. The abscissa is a list of amino acids ordered according to the maximum free
energy with which it interacts with all other amino acids.
use semi-random symmetric matrices with the same values of mean and variance as
the MJ matrix J and controlled differences between the largest values in each row.
In order to do that we construct a symmetric random matrix R, by first assigning
each matrix element a random uniformly distributed value from -1 to 0 and then
rescaling the matrix, such that the mean and the variance of the elements of matrices
J and R are the same. To control the differences between amino acid strengths we
use matrices of the form (1 - x)J + xR, where x E [0, 1].
As shown in Figure A-la there is a clear gradation of interaction free energies
(color scale in kBT units) in the MJ matrix, from the strong (lower left, blue color) to
weak (upper right, red color), enabling a clear ordering of the amino acids. For the MJ
matrix, the order of amino acids obtained by using the average interaction free energy
with other amino acids or that obtained by using the strongest interaction with other
amino acids is quite similar. Therefore, the computational results are unchanged
from that shown in Figure 2-5a if results using the MJ matrix are graphed with the
amino acids ordered according to their average interaction with other amino acids.














Figure A-2: Amino acid frequencies in selected TCRs for the semi-random matrix
(J + R)/2. (a) Color representation of the (J + R)/2 interaction matrix in units
of kBT. (b) Amino acid frequencies in selected TCRs for selection against different
numbers of self peptides M. The abscissa is a list of amino acids ordered according
to the maximum free energy with which it interacts with all other amino acids.
interaction energies with other amino acids and the strongest interaction of this amino
acid with all others are not correlated. Our analytical calculation (see Chapter 3)
shows that ordering amino acids according to their strongest interaction with other
amino acids is appropriate when there are many types of peptides in the thymus.
Therefore,we use this criterion in Figure A-lb (MJ matrix) and Figures A-2b and A-
3b (different random potentials). Results for the random potentials are qualitatively
similar to that for the MJ matrix when this criterion is used. We varied the random
potential by varying the difference between the maximum interaction free energies
characterizing the strongest and weakest amino acids (L and K), which is around 4kBT
for the MJ matrix. When we make this difference smaller (e.g., 2kBT as in Figure A-
2a), there is no clear trend of amino acid composition when TCR develop in a thymus
with a small number of types of peptides (Figure A-2b). Importantly, for many types
of peptides in the thymus, the qualitative trends obtained for the MJ matrix are
recovered. This is also true for even smaller differences between the strongest and
weakest amino acids (e.g., 0.6kBT) in Figure A-3. For random potentials, there are
more "bumps" in the distribution, but these disappear if an even larger number of
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Figure A-3: Amino acid frequencies in selected TCRs for the random matrix R.
(a) Color representation of the (J + R)/2 interaction matrix in units of kBT. (b)
Amino acid frequencies in selected TCRs for selection against different numbers of
self peptides M. The abscissa is a list of amino acids ordered according to the
maximum free energy with which it interacts with all other amino acids.
endogenous peptides are displayed in the thymus. For non symmetric interaction
matrices, statistical properties of selected TCRs are also similar to that we have
reported, and the order of amino acids is determined by the strongest interactions
with other amino acids (data not shown).
More complex interactions between peptide contact residues of TCRs and peptide
amino acids are used to check the robustness of our results. For example we present
the results (Figure A-4) for the following more complex potential, which includes
interactions with "nearest neighbor" amino acids
N -
En(t s') Ec + [J(tj, si) + 2{J(tj, s+1) + J(ti, si_}J . (A.1)
J(ti, si) is the interaction free energy between the ith amino acids on the variable
part of the TCR (ti) and the peptide (si), respectively, and N is the length of the
variable regions. In fact, the statistical properties of the TCR repertoire (Figure A-4)
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Figure A-4: The qualitative features of the post-thymic selection TCR repertoire are
robust to more complex interactions (Equation A. 1) between peptide contact residues
of the TCR and peptide amino acids. We show: (a) the number of important contacts,
(b) the amino acid composition of selected TCRs, (c) the distribution of contact
free energies between selected TCRs and antigenic pMHC and (d) the amino acid
composition of recognized antigenic peptides (E, - Ec = -75kBT, E --E, = -5kBT).
remain unchanged for any bilinear combination (COO > 0)
N N
Ein ) E + C0 QJ(t0 , s). (A.2)
a=1 #=1
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A.2 Robustness to changes in other parameters.
In this section we demonstrate a robustness of the results of the thymic selection
model presented in Chapter 2 to variations of model parameters, such as the softness
of positive and negative selection thresholds (Figure A-5), amino acid frequencies
of self peptides and TCRs (derived from human vs mouse proteome, Figure A-6),
TCR binding strengths to MHC (Figures A-7). Additionally we show how the results
depend on the number of self peptides in the thymus (Figure A-8) and how the
selection probability of TCRs depend on its binding strength to MHC (Figure A-9).
We also show that the results of the analysis of TCR-pMHC crystal structures are
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Figure A-5: Soft thresholds for positive and negative selection. The qualitative prop-
erties of the post-thymic selection TCR repertoire are robust to the nature of thresh-
olds for positive and negative selection. We show: (a) the number of important
contacts, (b) the amino acid composition of selected TCRs, (c) the distribution of
contact free energies -between selected TCRs and antigenic pMHC with a soft thresh-
old for positive selection and (d) the amino acid composition of recognized antigenic
peptides. The statistical properties of the TCR repertoire remain unchanged upon
introduction of soft thresholds for positive and negative selection. The statistical
properties of the TCR repertoire remain unchanged upon introduction of soft thresh-
olds for positive and negative selection (E., - Ec = -40kBT, E,, - E, = -5kBT,
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Figure A-6: Thymic selection using amino acid frequencies from mouse proteome.
Distributions of (a) the number of important contacts, (b) amino acid composition of
selected TCRs, (c) contact free energies between selected TCRs and antigenic pMHC,
and (d) amino acid composition of recognized antigenic peptides are similar whether
using amino acid frequencies from mouse or human proteome to generate TCRs and
self peptides. (E, - E = -40kBT, En - E, = -5kBT).
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Figure A-7: Thymic selection results for different TCR binding strengths to MHC.
We show: (a) the number of important contacts, (b) the amino acid composition of se-
lected TCRs, (c) the distribution of contact free energies between selected TCRs and
antigenic pMHC and (d) the amino acid composition of selected TCRs. For moderate
changes in TCR binding strengths to MHC (AEc > 0 corresponds to stronger bind-
ing), the amino acid composition of selected TCRs (b) changes slightly, such that
the properties of TCR recognition of antigenic peptides (a, d) remain unchanged.
(En - Ec = -40kBT, En - E = --5kBT).
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Figure A-8: Results of thymic selection as a function of the number of self peptides
M in the thymus. (a) The number of important contacts increase with number
of self peptides presented in the thymus. (b) The dependence of the amino acid
distribution of selected TCR sequences as a function of the number of self peptides
in the thymus. (c) The distribution of contact free energies between selected reactive
TCRs and antigenic peptides. (d) The dependence of the amino acid distribution
of recognized antigenic peptides as a function of the number of self peptides in the
thymus. Increasing the number of self peptides in the thymus results in more moderate
contacts and less weak and strong contacts. These results (particularly b) show
that as long as there are > 100 types of endogenous pMHC in the thymus, the
qualitative results reported in Chapter 2 would be obtained. (E, - Ec = -40kBT,
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Figure A-9: Probabilities of TCR selection. (a) Fraction of selected TCRs (Psei(Ec))
against one self-peptide (black curve) and many types of self-peptides (blue curve,
M = 10, 000) as a function of the threshold for negative selection E" - Ec, whereas
the gap between thresholds for negative and positive selection is kept constant at
En- E = -5kBT. At small values of En - Ec (strong binding of TCR to MHC)
negative selection is dominant - dotted lines show fraction of TCRs that are not
negatively selected. At large values of En -Ec (weak binding of TCR to MHC) positive
selection is dominant - dashed lines show fraction of TCRs that are positively selected.
(b) Numerically obtained probability density function of TCR binding strengths to
MHC (Ec values) in selected TCRs (Psei(Ec)) for selection against M self peptides.
Before selection Ec values are taken to be uniformly distributed (po(Ec)) on a narrow
interval (E,min, Ec,max) = (-35.5, -30.5)kBT. The probability density function of
TCR binding strengths to MHC after selection can be obtained analytically Psel(Ec) =
PO(Ec)Psei(Ec)/ f po(E)Psei(E)dE (cf. the left panel (a)). TCRs that bind more
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Figure A-10: Frequency distribution of amino acids in TCR that are in contact with
peptide. The ratio of amino acid frequencies derived from the list of amino acids
of TCRs in contact with peptides calculated from 18 available crystal structures of
TCR-pMHC(I) complexes with respect to the amino acid frequencies from human
proteome are presented in these graphs. The residues are said to be in contact with
each other if the Co-Ce distance is <6.5 A (black points). In a separate analysis,
any two residues are defined to be in contact if a water molecule cannot fit between
them (blue points). The dominance of weakly interacting amino acids is robust to
the definition of contact between residues. (a) The abscissa is divided into the two
types of strong amino acids (IVYWREL) and weak amino acids (QSNTAG) according
to reference (Zeldovich et al., 2007) (b) The amino acids on abscissa are ordered
from strongest (L) to weakest (K) according to the strongest interaction with another
amino acid using the MJ matrix. This ordering presents charged aminoacids (REDK)
as weak. In contrast, according to reference (Zeldovich et al., 2007), amino acids R
and E are strong, and amino acids D and K are not weak.
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Appendix B
Accuracy of prediction algorithms
for peptide binding affinities to
HLA and Mamu alleles
There are at present several HLA-peptide binding prediction methods. The perfor-
mance of these algorithms to identify new epitopes has recently been benchmarked
against experimental data (Peters et al., 2006). In general, artificial neural networks,
ANN, (Gulukota et al., 1997) and the stabilized matrix method, SMM, (Peters et al.,
2003) were found to be superior to other methods (Peters et al., 2006). We used the
ANN and the SMM (versions 2009-09-01 and 2007-12-27) prediction tools provided
by the IEDB (Peters et al., 2005). Accuracy of prediction tools was tested against
experimental data downloaded from the IEDB in September 2009. These experi-
mental data were obtained by two methods: competition assays, in which purified
MHC and radioactive labelling are used; and association studies, in which purified
MHC and fluorescence labelling are used. Data obtained from the two methods
show significant correlations of measured binding affinities (as measured by half-
maximum inhibitory concentration (IC50 ) and half-maximum effective concentration
(EC5 0 )) (Rao et al., 2009). Prediction tools were tested against experimental data
for accuracy of classifying peptides into binders (IC5 0 < 500 nM) and non-binders
(IC5 0 > 500 nM); the chosen thresholds are commonly accepted values (Rao et al.,
119
2009). We also tested how well these tools predict absolute measured affinity values,
not just classification of binders and non-binders, which is dependent on the chosen
thresholds. The accuracy of the prediction tools thus determined are summarized in
Table B.1 and Figures B-1-B-3. We excluded all HLA and Mamu alleles for which
there was not enough experimental data (at least 50 binders and 50 non-binders) or
prediction tools were not sufficiently accurate. For each HLA and Mamu allele, the
most accurate prediction tool was used to predict the fraction of unique peptides de-
rived from the human and macaque proteome (Homo-sapiens.GRCh37.55.pep.all.fa
and Macacamulatta.MMUL 1.56.pep.all.fa obtained from Ensembl (Hubbard et al.,
2009)) that can bind to that allele. We focused only on the binding abilities of pep-
tides of 9 amino acids to HLA molecules, because there is not enough experimental
data available for the binding affinities of peptides of 8, 10 and 11 amino acids to
HLA-B*5701 and the other relevant HLA-B alleles that emerged from our analyses
(HLA-B*2705, HLA-B*0702 and HLA-B *3501).
B.1 Measures of accuracy of prediction algorithms
For each HLA and Mamu allele we have analyzed the accuracy of four predictive
algorithms available from the Immune Epitope Database (IEDB): ANN and SMM
(versions 2009-09-01 and 2007-12-27). Accuracy was tested against experimental data
(downloaded from the IEDB) of measured peptide binding affinities (IC50 ) to HLA
and Mamu molecules. Only those HLA and Mamu alleles were kept in the analysis for
which there was enough experimental data (at least 50 binders and 50 non-binders).
First we tested how good the predictive algorithms are in classifying peptides into
binders (IC50 < 500 nM) and non-binders (IC50 > 500 nM). We counted the number of
true positives T (correctly predicted binders), true negatives T, (correctly predicted
non-binders), false positives Fp (incorrectly predicted binders) and false negatives F.
(incorrectly predicted non-binders). The accuracy of the algorithm is defined as
ACC = .p (B.1)
T + Tn + Fp + Fn
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Most algorithms for which there were sufficient experimental data were very accurate
(more than 80%, Table B.1). Commonly used measure of accuracy is also Matthews
correlation coefficient:
TpT~ - FFMCC = " " (B.2)
v/PMP'M'
where P (M) and P (M) are numbers of experimental binders (non-binders) and pre-
dicted binders (non-binders) respectively. The closer the MCC is to the value 1, the
higher the accuracy of the prediction algorithm. Most algorithms had a MCC value
in the range of 0.6 to 0.9 (Table B.1). The accuracy of predictive algorithms is often
displayed with a Receiver operating characteristic (ROC) curve (Swets, 1988). The
ROC curve shows how the true positive rate, TP/(TP + FN), and the false positive
rate, FP/(FP + TN), change as the threshold that separates predicted binders from
non-binders is varied (see Figures B-1-B-3). A quantitative measure of the predictive
algorithm accuracy is the area under the ROC curve (AUC). The closer the AUC is
to the value 1, the higher the accuracy of the prediction algorithm. Most algorithms
were very accurate and had an AUC value above 0.9 (Table B.1).
Second we tested how good the predictive algorithms are at determining the actual
value of the binding affinity, IC50 . Because binding affinities span a huge range of
values, a commonly used difference of logarithms
f (i) = ln(predicted IC50 ) - ln(measured IC 5 0 ), (B.3)
was taken as a measure of the accuracy of predicted binding affinity of the i-th peptide.
When experiments reported that binding affinity has a value greater than some value,
LIC 50 , we defined
f (i) f0; predicted IC50 > LIC50 (.4)
ln(predicted IC50 ) - ln(LICso); predicted IC50 < LIC50
Similarly, when experiments reported that binding affinity has value lower than some
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value, HIC5 0 , the accuracy was defined as
0; predicted IC50 < HIC50f(i =W (B.5)
ln(predicted IC50 ) - ln(HICso); predicted IC50 > HIC50
Overall accuracy of the predictive algorithm was determined from average bias A ln(y)
and average root mean square error a:
IN 2 N 2
A ln(y) = f (i) o [f (0)] . (B.6)
Table B.1 reports accuracies of all 4 predictive algorithms for each HLA-B allele and
Mamu allele for which there was enough experimental data available. HLA-A alleles
were not studied, because they are not associated with control of HIV (Price et al.,
2009). In assessing the accuracy of the algorithms using Equations (B.1)-(B.6), we
did not include experimental data for which even a bound (less than or greater than)
for IC50 was not reported.
If average bias A ln(y) > 0 (A ln(y) < 0), then the predictive algorithm on average
overestimates (underestimates) the value of binding affinity. Average bias of predic-
tive algorithms can affect values of predicted fraction of peptides that can bind to a
certain allele. In Table B.1, alleles for which there are no accurate predictive algo-
rithms (all 4 predictive algorithms have large normalized bias |A ln(y)/Ul > 0.06) are
marked with white. The most accurate algorithm (bold font in Table B.1) for those
alleles is taken to be the one with the least value of normalized bias (IA ln(y)/Ul). In
Table B.1, alleles for which there is at least one accurate predictive algorithm (nor-
malized bias A ln(y)/o| < 0.06) are marked with yellow. If there is more than one
accurate predictive algorithm for a given allele, the most accurate predictive algorithm
(bold font in Table B.1) was selected to be the one with the least value of average
root mean square error, o, among the accurate predictive algorithms (for all of which
|A ln(y)/ul was very small). Different choices of threshold for normalized bias that
separate accurate and inaccurate predictive algorithms lead to only small changes in
Table B. 1. For example, if we choose the threshold to be 0.08, we get one more allele
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(HLA-B*1517) with at least one accurate predictive algorithm and the most accurate
algorithm would change for two alleles (HLA- B*1517 and HLA-B*4403).
For each HLA and Mamu allele we used the most accurate predictive algorithm to
predict the fraction of peptides derived from human and macaque proteome that can
bind to given allele. There were ~ 107 (~ 106) unique peptide sequences in human
(macaque) proteome. We used only HLA-B alleles (marked with yellow in Table B. 1)
for which there is at least one accurate predictive algorithm available to determine
the typical binding fraction for HLA-B alleles (median - 0.013 and average - 0.015).
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Table B.1: Accuracy of predictive algorithms for 9-mer peptide binding by HLA-B
and Mamu alleles.
allele BF predictive algorithm N ACC MCC AUC A In(y) a JA In(y)/al
HL A-B*0702 0.016 ann (2009-09-01) 2301 94.1 0.840 0.982 0.108 1.065 0.101
0.018 ann (2007-12-27) 93.9 0.841 0.981 -0.061 1.074 0.057
0.017 smm (2009-09-01) 92.8 0.807 0.973 0.150 1.419 0.105
0.024 smm (2007-12-27) 92.3 0.795 0.971 0.079 1.409 0.056
HLA-B*0801 0.011 ann (2009-09-01) 1560 91.2 0.759 0.960 0.246 1.553 0.159
0.023 ann (2007-12-27) 89.5 0.744 0.958 -0.260 1.603 0.162
0.012 smm (2009-09-01) 89.0 0.701 0.953 0.254 1.733 0.147
0.038 smm (2007-12-27) 88.9 0.724 0.951 -0.191 1.700 0.112
HLA-B*1501 0.028 ann (2009-09-01) 2342 87.3 0.713 0.948 0.243 1.519 0.160
0.035 ann (2007-12-27) 87.8 0.727 0.946 -0.061 1.470 0.041
0.023 smm (2009-09-01) 85.4 0.668 0.939 0.248 1.640 0.151
0.036 smm (2007-12-27) 86.4' 0.694 0.942 0.005 1.564 0.003
HLA-B*1503 0.068 ann (2009-09-01) 390 88.2 0.586 0.930 0.699 1.934 0.361
0.077 ann (2007-12-27) 89.2 0.598 0.940 0.391 1.823 0.214
0.313 smm (2009-09-01) 88.2 0.541 0.929 0.301 1.789 0.168
0.451 smm (2007-12-27) 89.5 0.580 0.917 0.266 1.898 0.140
HLA-B*1517 0.050 ann (2009-09-01) 678 95.4 0.904 0.989 0.234 1.244 0.188
0.059 ann (2007-12-27) 95.0 0.895 0.987 -0.104 1.323 0.078
0.079 smm (2009-09-01) 93.5 0.863 0.984 0.125 1.437 0.087
0.141 smm (2007-12-27) 94.1 0.877 0.985 -0.105 1.450 0.072
HLA-B*1801 0.009 ann (2009-09-01) 1161 94.7 0.730 0.969 -0.034 1.081 0.031
0.008 ann (2007-12-27) 94.9 0.760 0.974 -0.205 1.110 0.185
0.010 smm (2009-09-01) 93.5 0.667 0.964 -0.004 1.329 0.003
0.012 smm (2007-12-27) 94.0 0.707 0.963 -0.120 1.355 0.089
HLA-B*2705 0.014 ann (2009-09-01) 1701 95.3 0.792 0.977 -0.024 0.775 0.031
0.017 ann (2007-12-27) 94.9 0.797 0.982 -0.106 0.843 0.125
0.016 smm (2009-09-01) 93.8 0.728 0.968 -0.028 0.972 0.029
0.017 smm (2007-12-27) 93.5 0.714 0.966 -0.013 0.988 0.013
HLA-B*3501 0.024 ann (2009-09-01) 652 79.8 0.611 0.898 0.455 1.893 0.241
0.027 ann (2007-12-27) 80.8 0.622 0.881 0.203 2.041 0.100
0.034 smm (2009-09-01) 77.5 0.558 0.867 0.476 2.129 0.224
0.042 smm (2007-12-27) 77.6 0.566 0.873 0.482 2.104 0.229
HLA-B*3901 0.016 ann (2009-09-01) 478 94.4 0.832 0.987 -0.088 0.861 0.103
ann (2007-12-27)
0.022 smm (2009-09-01) 92.7 0.783 0.977 -0.183 1.083 0.170
smm (2007-12-27)
HLA-B*4001 0.011 ann (2009-09-01) 1832 96.0 0.845 0.985 0.082 0.945 0.087
0.010 ann (2007-12-27) 95.2 0.814 0.976 -0.011 1.181 0.009
0.015 smm (2009-09-01) 94.2 0.783 0.975 0.078 1.320 0.059
0.010 smm (2007-12-27) 93.2 0.728 0.970 0.222 1.455 0.153
HLA-B*4002 0.013 ann (2009-09-01) 256 91.8 0.837 0.981 0.335 1.217 0.275
0.019 ann (2007-12-27) 81.6 0.640 0.909 -0.621 1.850 0.336
0.019 smm (2009-09-01) 84.4 0.686 0.939 0.061 1.637 0.037
0.028 smm (2007-12-27) 82.8 0.657 0.917 -0.219 1.763 0.124
HLA-B*4402 0.003 ann (2009-09-01) 1052 95.8 0.640 0.987 -0.124 0.937 0.133
0.004 ann (2007-12-27) 96.6 0.742 0.984 -0.216 0.987 0.219
0.001 smm (2009-09-01) 94.5 0.456 0.978 -0.105 1.063 0.099
smm (2007-12-27) 1 1
HLA-B*4403 0.006 ann (2009-09-01) 260 87.3 0.662 0.947 -0.103 1.382 0.075
0.007 ann (2007-12-27) 86.5 0.659 0.926 -0.676 1.648 0.410
0.006 smm (2009-09-01) 86.5 0.640 0.924 -0.047 1.597 0.029
0.011 smm (2007-12-27) 81.9 0.535 0.880 -0.340 1.789 0.190
HLA-B*4501 0.013 ann (2009-09-01) 249 95.2 0.885 0.989 -0.077 0.944 0.081
0.011 ann (2007-12-27) 87.1 0.700 0.954 -0.366 1.526 0.240
0.012 smm (2009-09-01) 89.2 0.736 0.960 0.022 1.534 0.015
0.025 smm (2007-12-27) 85.9 0.670 0.938 0.057 1.810 0.032
HLA-B*5101 0.002 ann (2009-09-01) 849 89.4 0.609 0.955 0.160 1.461 0.109
0.004 ann (2007-12-27) 89.3 0.669 0.944 -0.353 1.601 0.221
0.001 smm (2009-09-01) 87.8 0.531 0.934 0.158 1.675 0.094
0.007 smm (2007-12-27) 87.8 0.594 0.931 -0.185 1.651 0.112
HLA-B*5301 0.008 ann (2009-09-01) 399 92.5 0.848 0.973 0.052 1.636 0.032
0.006 ann (2007-12-27) 89.0 0.780 0.953 -0.228 1.745 0.130
0.017 smm (2009-09-01) 86.7 0.732 0.942 0.210 1.993 0.105
0.025 smm (2007-12-27) 86.0 0.721 0.934 0.165 1.908 0.086
HLA-B*5401 0.010 ann (2009-09-01) 404 91.8 0.818 0.974 0.313 1.414 0.222
0.009 ann (2007-12-27) 87.1 0.729 0.947 -0.370 1.742 0.212
0.024 smm (2009-09-01) 89.1 0.754 0.951 0.174 1.775 0.098
0.027 smm (2007-12-27) 87.4 0.723 0.948 0.015 1.786 0.008
HLA-B*5701 0.007 ann (2009-09-01) 1162 96.6 0.837 0.988 0.000 0.640 0.001
0.008 ann (2007-12-27) 95.2 0.777 0.984 -0.230 0.901 0.255
0.005 smm (2009-09-01) 94.1 0.696 0.980 -0.045 0.899 0.050
0.006 smm (2007-12-27) 1 1 94.5 0.723 0.984 -0.087 0.871 0.100
BF fraction of 9-mer peptides (derived from human and macaque proteome) that are predicted to bind
to HLA-B and Mamu alleles
N number of available experimental measurements used to test prediction algorithms
ACC % accuracy of classifying peptides into binders and non-binders (Equation B.1)
MCC Matthews correlation coefficient (Equation B.2)
AUC area under the ROC curve
A ln(y), a average bias and error of predicted binding affinity value IC 5 0 (Equation B.6)
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fraction of 9-mer peptides (derived from human and macaque proteome) that are predicted to bind
to HLA-B and Mamu alleles
number of available experimental measurements used to test prediction algorithms
% accuracy of classifying peptides into binders and non-binders (Equation B.1)
Matthews correlation coefficient (Equation B.2)
area under the ROC curve
average bias and error of predicted binding affinity value IC50 (Equation B.6)
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Table B. 1 continued:
allele BF predictive algorithm N ACC MCC AUC A In(y) r lA ln(y)/-r
HLA-B*5801 0.016 ann (2009-09-01) 1947 95.3 0.838 0.983 0.052 0.956 0.054
0.012 ann (2007-12-27) 95.0 0.830 0.980 0.016 1.010 0.016
0.017 smm (2009-09-01) 94.0 0.792 0.979 -0.039 1.194 0.033
0.014 smm (2007-12-27) 93.9 0.788 0.977 0.093 1.205 0.077
Mamu-A*01 0.020 ann (2009-09-01) 692 87.4 0.749 0.944 0.150 1.597 0.094
0.021 ann (2007-12-27) 85.8 0.718 0.929 -0.201 1.768 0.114
0.028 smm (2009-09-01) 85.5 0.712 0.927 -0.001 1.909 0.001
0.028 smm (2007-12-27) 85.0 0.701 0.920 0.027 1.892 0.014
Mamu-A*02 0.046 ann (2009-09-01) 249 83.5 0.677 0.930 0.421 2.135 0.197
0.031 ann (2007-12-27) 82.3 0.646 0.925 0.060 2.322 0.026
0.064 smm (2009-09-01) 82.3 0.645 0.928 0.109 2.057 0.053
0.064 smm (2007-12-27) 82.3 0.645 0.918 0.101 2.175 0.046
Mamu-A*11 0.021 ann (2009-09-01) 367 91.3 0.823 0.974 -0.034 1.532 0.022
0.018 ann (2007-12-27) 90.5 0.806 0.961 -0.056 1.685 0.033
0.044 smm (2009-09-01) 89.1 0.778 0.948 0.147 1.908 0.077
0.054 smm (2007-12-27) 88.6 0.767 0.951 0.129 1.864 0.069
Mamu-B*17 0.004 ann (2009-09-01) 589 88.6 0.763 0.963 0.104 1.101 0.095
0.001 ann (2007-12-27) 71.3 0.403 0.798 1.141 2.397 0.476
0.005 smm (2009-09-01) 83.5 0.658 0.929 0.069 1.392 0.050
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Figure B-1: Scatter plots show comparison between experimentally measured and
predicted binding affinities of 9-mer peptides to HLA-B*5701 allele (a) and HLA-
B*2705 (b). For both alleles the best predictive algorithm (Table B.1) was used.
Green data points correspond to measurements, which report exact binding affinity.
Red data points correspond to measurements, which report that IC50 is larger than
that corresponding to its value on the abscissa. Solid lines represent threshold value
500 nM, which divides binder and non-binder peptides. Dashed lines would repre-
sent perfect match between predicted and experimentally measured binding affinities.
The numbers reported in each quadrant correspond to the number of displayed data
points. These numbers are used to calculate accuracy (ACC) and Matthews corre-
lation coefficient (MCC). (c) and (d) show the ROC curves for the best predictive
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Figure B-2: The predictive algorithms for HLA-B*0801 are not very accurate (see
also Table B.1). Scatter plots show comparison between experimentally measured
and predicted binding affinities of 9-mer peptides to HLA-B*0801 allele for two pre-
dictive algorithms: smm (2009-09-01) on left and smm (2007-12-27) on right. Green
data points correspond to measurements, which report exact binding affinity. Red
data points correspond to measurements, which report that IC50 is larger than that
corresponding to its value on the abscissa. Solid lines represent threshold value 500
nM, which divides binder and non-binder peptides. Dashed lines would represent per-
fect match between predicted and experimentally measured binding affinities. Newer
algorithm (a) on average tends to overestimate IC50 value, which results in predicting
fewer peptide binders. Older algorithm (b) on average tends to underestimate IC50
value, which results in predicting more peptide binders. The numbers reported in
each quadrant correspond to the number of displayed data points. These numbers
are used to calculate accuracy (ACC) and Matthews correlation coefficient (MCC).
(c) and (d) show the ROC curves for the two predictive peptide binding algorithms
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Figure B-3: The predictive algorithms for HLA-B*3501 are less accurate than that fo
HLA-B*5701, HLA-B*0702, and HLA-B*2705 (see also Table B.1). (a) Scatter plot
show comparison between experimentally measured and predicted binding affinities
of 9-mer peptides to HLA-B*3501 allele for the most accurate predictive algorithm
ann (2007-12-27). Green data points correspond to measurements, which report ex-
act binding affinity. Red data points correspond to measurements, which report that
IC5o is larger than that corresponding to its value on the abscissa. Solid lines repre-
sent threshold value 500 nM, which divides binder and non-binder peptides. Dashed
lines would represent perfect match between predicted and experimentally measured
binding affinities. The algorithm on average tends to overestimate IC5o value, which
results in predicting a smaller peptide binding fraction than reality. The numbers
reported in each quadrant correspond to the number of displayed data points. These
numbers are used to calculate accuracy (ACC) and Matthews correlation coefficient






In this Appendix, we describe in details the dynamical host-pathogen interaction
model that was briefly described in Chapter 4 (Figure 4-2). We present also a sim-
plified model of host-pathogen interactions (Section C.2) and show that qualitative
results about the effects of cross-reactivity are robust to variations in parameters and
model assumptions (Section C.3).
C.1 Host-pathogen interaction dynamics model
We constructed a small model of HIV with distinct epitopes and sequence diver-
sity, based in part on models developed previously (Nowak et al., 1995; Wodarz and
Thomsen, 2005). The virus is modelled as displaying L epitopes, each consisting of
M amino acid residues that may be of N types. Different viral strains arise through
point mutations at the amino-acid sites, giving (NM)L distinct strains. The number
of different pMHC types is L x N", because peptide sequences at epitope positions
1... L are considered to be distinct. The system of ordinary differential equations
corresponding to the model in Figure 4-2 and based on previous work (Wodarz and
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Thomsen, 2005) is as follows:
d Vdt" = k"In - kcVn + km (V-V), (C.1)
n: m
d t









d" k'jn - k'Pc (C.5)
dt 8 0nj
dT-APC
dt = kaTi(j P j (C.6)
ndj
dt' = -kTTO +T kT oP c + kraMi 
-1UjPP C, (C.7)
dt - TO atI '
nJ nj
d~ijm  -2kpTi'm l)pkTim, 8
dt (C8
dT*
-- d = 2k T( 1- -kdtTi" ( C.9)
=t 2k,iD1 d~ 
dM.
dt' = kmT* - kdMi - kraMi Z O- P PC. (C.10)
n~j
Target CD4+ T cells, P, are infected by free virus particles, where V denotes
virions of strain n. In denotes CD4+ T cells infected by virus of strain n, Pnj is a
pMHC complex of peptide j derived from viral strain n, displayed on the surface of
the infected cell, P Jc is a pMHC displayed by APCs and T is a naive CD8+ T cell
of clonotype i. Activated T cells undergo D rounds of cell division before becoming
effector CTLs; Ti0 is an activated CD8+ T cell of type i that has not yet begun dividing
and Ti are the dividing cells, where m runs from 1 to D - 1. Effector CTLs, T*,
differentiate into memory CD8+ T cells, Mi, which are activated upon re-exposure to
pMHC.
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If T-cell clone i recognizes pMHC j, oujj is 1, and 0 otherwise. In Equation (C.1),
En:m denotes the sum over viral strains m that are Hamming distance 1 away from
strain n. That is, only point mutations are allowed. The third term of Equation (C.4)
ensures that if an infected cell is killed, the pMHC bound on its surface must also
disappear; dIS"" denotes the third term of Equation (C.3), which describes killingdt
of an infected cell by CTLs that recognize pMHC on its surface. Simulations were
performed using ode45 and odel5s solvers in MATLAB. A further dynamic model
(Section C.2), which does not incorporate target cell limitation and allows unlimited
expansion of activated CTLs, was also developed to show robustness of our results to'
model assumptions (Section C.3).
Rate constants used in the models are given in Table C.1, and are in keeping with
values reported in the literature. We assume a concentration of 106 CD4+ T cells per
ml blood before infection, with 1% of these cells activated and thus initial targets for
HIV infection (Sachsenberg et al., 1998; Stafford et al., 2000). The initial conditions
of infection in the simulations were one infected CD4+ T cell per ml of plasma and
a naive-CD8+ repertoire size of one cell per ml of each clonotype. We assume that
the number of epitopes, length of each epitope, and number of amino acids (L, M, N)
are all 2, giving 8 pMHC types and 16 possible viral strains. The number of CD8+
clonotypes was chosen to be 20.
The interplay between antigen and immune receptor diversity is captured in this
model through variability in auj and viral fitness. Different fitness levels for different
strains of the virus are modelled by randomly selecting k, the virus proliferation rate,
for each strain from a uniform distribution between 0 and 2,000 per day (Althaus and
de Boer, 2008; Parera et al., 2007), with the assumption that the infecting strain
has the maximum fitness. The matrix oij encodes the ability of T cells to recognize
pMHCs. We generate orj in such a way as to mimic the results of the thymic selection
model (Figure 4-1b), to investigate the effects of those predictions on host -pathogen
dynamics. That is, we assume that T-cell repertoires restricted by different HLA types
differ in the interaction free energies of their TCR-pMHC contacts, and generate auj
accordingly using a type of randoni-energy-like model (Figure C-1). The interaction
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Table C.1: Parameters of host-pathogen interaction model shown in Figure 4-2:
Parameter [Symbol [ Value Units ' References
Initial target cell P(t 0) 3 x 104 cell ml-' (Sachsenberg et al.,
concentration 1998)
Maximum virus k, 2000 virions (cell (Ramratnam et al.,
replication day)-1 1999; Ribeiro, 2007)
Virus clearance kc 20 day- 1  (Ramratnam et al.,
1999)
Mutation rate km 2.2 x 10-5 mutations (Huang and Wooley,
(base cycle)- 1  2005)
Target cell pro- kb 1000 (cell day)-
duction
Target cell death kd 0.1 day- 1
Target cell infec- kt 6.5 x 10-7 ml (virus (Stafford et al., 2000)
tion day)- 1
Infected cell k' 0.15 day- (Bonhoeffer et al.,
death 2003)




Peptide off-rate ko, k' 1 day- 1  (Peter et al., 2001)
Activated CD8+ kp 3 day- 1  (Murali-Krishna
expansion et al., 1998)




Memory cell ac- kra 8 x 10-6 ml (cell
tivation day) 1
Effector CD8+ kdt 0.5 day-1 (de Boer et al., 2001)
cell death
Differentiation km 0.008 day-1
of effector to
memory cell
Memory cell kdm 0.015 day -1 (Ladell et al., 2008)
death
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Figure C-1: Random energy-like model for generating oij, the matrix describing
recognition of pMHCs by CD8+ T cells. The degree of cross-reactivity in the simu-
lation depends on the uniform distribution from which interaction strengths between
individual epitope residues and the TCRs are randomly selected (right). A higher
upper limit of the pairwise distribution corresponds to a higher mean and broader
distribution of the overall (summed) TCR-pMHC interaction strengths (left). As
recognition is considered to occur above a threshold, a broader distribution results
in more frequent recognition of pMHCs by T cells in the model, and thus higher
cross-reactivity.
free energy between a T cell and an epitope is given by Ea J(i, ja), where J(i, ja) is
the interaction free energy between T cell of clonotype i and residue a on epitope j.
Similar to the models used for thymic selection, the total interaction free energy is
taken to be the sum of the individual residue interactions and recognition is said to
occur when it exceeds a recognition threshold (in the dynamic model, T-cell sequences
are not specified explicitly). J(i, ja) is a random variable chosen from a uniform
distribution, and the width of the distribution determines the probability that the
summed interaction energy falls above the threshold, and thus the probability that a
peptide is recognized by a given T cell. Repertoires generated in this way approach
a Gaussian distribution of interaction energies, and the distribution shifts and thus
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cross-reactivity increases when the uniform distribution from which J(i, Ja) is selected
is wider. Generating aoj in this way allows us to describe variable cross-reactivities of
the T-cell repertoire (both intra- and interepitope), and also accounts for correlated
interaction energies and thus recognition probabilities of similar peptide sequences.
C.2 Host-pathogen interaction dynamics for sim-
plified model
The following dynamical model is similar to that in Figure 4-2, but is without the
effects of target cell limitation, finite CTL expansion, and CD8+ memory. Similar
models have been studied previously (Handel and Antia, 2008). The following equa-
tions describe the model (schematic in Figure C-2):
dVn = kIn - kcVn + km Z(V - V), (C.11)
dI " kVI 
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Rate constants for this model are given in Table C.2, where rate constants governing
virus and CD4+ dynamics are generally adopted from the literature. Approximate
rate constants for virus and CD4+ cell turnover are available from studies in which
patient viral loads were perturbed by antiretroviral treatment or plasma apheresis,













Figure C-2: Schematic of a model for host-pathogen dynamics that is simpler than
that shown in Figure 4-2 (henceforth termed, simplified model). The virus mutates,
infects target CD4+ T cells, and is cleared. Infected CD4+ T cells produce more free
virus, and die. Infected cells present viral peptides in complex with HLA molecules
for a period (until peptides unbind from HLA). Activated (effector) CD8+ T cells
produced by recognition of viral epitopes on APCs proliferate and kill infected cells
bearing their cognate peptide-HLA complex
Wei et al., 1995). Predicted rate constants for infected CD4+ cell death range from
about 0.1 to 1 day-' (Bonhoeffer et al., 2003). This rate constant accounts for cell
death due to virus cytotoxicity as well as clearance by effector CTLs and antibodies,
and thus is considered an upper bound for kd in our model, which describes infected
cell death by means other than CTL killing. Estimates for the percentage of infected
cell death attributable to the CTL response range from 10% to 90% (Althaus and
de Boer, 2008; Asquith et al., 2006). Constants for reactions involving CD8+ cells
are chosen to give realistic peak and setpoint (in the model described in the main




Table C.2: Parameters of simplified host-pathogen interaction model shown in Fig-
ure C-2 (parameters not listed are the same as in Table C.1):
Parameter I Symbol] Value Units
Target cell concentration t 110
Infected cell death kd 0.1 day'
Presentation of pMHC on k8, k' 800 day-1
infected cells, APCs
Peptide off-rate ko, k1 40 day'
Activated CTL expansion k, 0.2 day-1
Rate of CTL activa- ka / kk 6 x 10- ml (cell day)-'
tion/infected cell killing
(base cycle)- is converted to - 0.22/(L x M) mutations (amino acid day)-' using an
estimate of 1 day for a replication cycle (Perelson et al., 1996) and - 104 base pairs
for the size of the virus. In the chronic infection model, the number of cell divisions
(D) is taken to be 8 (Wodarz and Thomsen, 2005).
If the parameters in the model are chosen such that the virus is able to take hold
and expand (Perelson and Nelson, 1999), the qualitative results related to the effects
of cross-reactivity are insensitive to the choice of rate constant parameters. This is
demonstrated in Figure C-7 for 100-fold variation of the rate constant governing T
cell activation, and results were found to be similarly insensitive to variations in the
other rate constants (data not shown).
C.3 Robustness of the effects of cross-reactivity to
variations in parameters and models.
Figures in this section demonstrate that the qualitative results about the effects of
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Figure C-3: Simulation results using the simplified model. HIV viral loads versus
time for different cross-reactivities (CR) of the CD8+ T cell repertoire, corresponding
to the model in Figure C-2. The black curve corresponds to highly cross-reactive case
and the red curve corresponds to lower cross-reactivity. Each curve is averaged over
500 simulations (each simulation represents a person).
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Figure C-4: As in Figure 4-4, but for the simplified model (schematic in Figure C-2).
When more clones recognize the infecting and emerging strains (left, bottom), the
emerging mutant strain (green) is kept in check (left, top). However, when cross-
reactivity is low, the likelihood that the mutant strain goes unrecognized is higher
(bottom, right), and the mutant strain achieves a large percent contribution of the


































Figure C-5: Anticorrelation of simulated peak viral loads with percent contribution
of the dominant epitope to the total CTL response for the model in Figure C-2.
Percent contribution is calculated as the number of activated CTLs recognizing the
immunodominant epitope over the total number of activated CTLs in the simulation.
The immunodominant epitope is defined as the epitope recognized by the largest
number of CTL clones. Lower percent contributions are achieved when the CD8+
T cell repertoire is less cross-reactive, which also correlates with higher viral loads,
as found experimentally by Altfeld and coworkers (Streeck et al., 2009). The black
points and bars correspond to the average and standard deviation of 500 simulations
for each level of T cell cross- reactivity, with the level of cross-reactivity increasing
from left (probability of 0.28 that a given epitope is recognized by a particular CTL)
to right (probability 1). Varying other parameters in the model, including peptide
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Figure C-6: Peak viral load versus average number of CD8+ clones recognizing a
pMHC in each simulation in the simplified model (schematic in Figure C-2). "Escape"
is taken to mean that the population size of a mutant viral strain has become larger
than that of the infecting strain at some point during the simulation time (0 to 80
days). As exemplified in Figure 4-4, the smaller the number of clones recognizing each
pMHC (corresponding to lower cross-reactivity), the higher the chance of escape.
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Figure C-7: Insensitivity of qualitative results to changes in CD8+ T cell activation
rate for the simplified model (schematic in Figure C-2). Left panels show simulation
results with varying cross reactivity for activation rate 10ka (ka given in Table C.2),
while right panels show results for ka/lO0. Insensitivity of qualitative results to pa-
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Figure C-8: Anticorrelation of simulated viral loads with percent contribution of the
dominant epitope to the total CTL response, as in Figure C-5, but corresponding to
the model described in Chapter 4 and Section C.1 (Figure 4-2). Viral load and %
contribution were calculated at day 200 in the simulations, to approximate viral load
setpoint. Both models give qualitatively similar results. Thus, the result that a cross-
reactive repertoire results in low viral loads and high % contribution of responses to
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Figure C-9: As in Figure C-6, but for the model described in Chapter 4 and Sec-
tion C.1 (Figure 4-2). As the number of clones recognizing a pMHC increases, the
setpoint viral load and probability of escape decrease.
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Figure C-10: Insensitivity of qualitative results to changes in CD8+ T cell activation
rate for the model described in Chapter 4 and Section C.1 (Figure 4-2). Left panels
show simulation results with varying cross reactivity for activation rate 10ka (ka given
in Table C.1), while right panels show results for ka/10. The setpoint viremia level
depends strongly on ka, but the qualitative correlation between viral load and %
contribution of the immunodominant epitope (a and b) and the number of clones
targeting a given pMHC (c and d) is the same. The same insensitivity of qualitative
results to parameter variation was found for other rate constants in the model also
(not shown). Note that for a lower activation rate (right panels), the probability of
escape is reduced (fewer green points), because of the lower overall immune pressure



















Figure C-11: Setpoint viral load versus % contribution of immunodominant epitope,
as in Figures C-5 and C-8, but where the rate of peptide presentation (not cross-
reactivity), is varied. Points correspond to k, values of 200, 100, 40, 20, 10, 5, and
1 (day- 1 ), with faster presentation of pMHC corresponding to reduced peak viral
loads. One potential effect of B57 binding fewer peptides is that the cell-surface con-
centration of immunogenic peptides could increase, because competition with other
peptides for binding to MHC would be reduced. This would then be an additional
mechanism for control of viral load. Increasing k, has the effect of raising cell-surface
concentration of pMHC and reducing viral load. As the figure shows, varying only
this parameter leads to correlation of high % contribution with high viral loads, in
contrast to the result of Altfeld and coworkers (Streeck et al., 2009). Variation of
other rate constants in the model gave similar results or had no effect on % con-
tribution (not shown). Therefore, only varying the cross-reactivity recapitulates the
experimental results. The issue of peptide presentation could be important if HLA
molecules like HLA-B*5701 presented far fewer HIV epitopes and so, due to less com-
petition, these epitopes were presented faster, and hence, in greater amounts. We
have used the predictive algorithms and the published HIV proteome (HXB2) to esti-
mate the number of HIV epitopes that can bind to the alleles we have identified from
our data (Figure 4-5) to be associated with control or progression. Approximately 40
peptides can bind to HLA-B*5701 and HLA-B*0702 and approximately 60 peptides
can bind to HLA-B*2705 and HLA-B*3501. Thus, the number of HIV peptides that
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